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ABSTRACT
HDAC3 IS A CRITICAL REGULATOR OF NEURAL CREST
PROGENITOR CELL BIOLOGY
Nikhil Singh
Jonathan A. Epstein

Vertebrate embryogenesis relies on the coordinated development of
multiple progenitor cell pools. Specific transcriptional programs regulate the
specification, expansion, migration and eventual differentiation of these
progenitor cell populations, and tight control of these programs is essential for
normal development to occur. Class I histone deacetylases (Hdacs), including
Hdac3, play critical roles in regulating gene transcription, through both epigenetic
and non-epigenetic means. In this dissertation, I use mouse genetics to explore
the previously undescribed role of Hdac3 in regulating neural crest progenitor cell
behavior. By genetically deleting Hdac3 in premigratory neural crest cells, I use in
vivo and ex vivo techniques to show that Hdac3 plays crucial roles in multiple
facets of neural crest development, and that transcriptional programs involved in
progenitor cell survival and differentiation are all under the control of this
important enzyme.
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Chapter 1. Introduction

Summary
Developmental biology is among the oldest and most well established
fields in the basic biological sciences. From their earliest incursions into this field,
developmental biologists have been concerned with a single fundamental
question:

How can a single cell give rise to the all of the cell types and structures that
comprise a complex organism?

In much the same way that this single cell, the zygote, divides before
giving rise to the rich diversity of cell types, the multitude of tissues, and the
intertwined organ systems that comprise a multicellular organism, the field of
developmental biology has itself divided before giving rise to new applications
and entirely new areas of study, which are similarly intertwined. This field has
been roughly subdivided into the studies of the growth and survival of cells, the
specification and differentiation of cells, and morphogenesis of complex
structures and organ systems. Indeed, the realization that development consists
of these distinct but coordinated core processes was itself a critical advancement
in the field.
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Recent efforts in developmental biology have focused on understanding
the molecular mechanisms underpinning these core developmental processes.
Our burgeoning molecular understanding of these processes has not only helped
us make inroads into answering developmental biologyʼs most fundamental
question, but it has profoundly influenced the study and categorization of
congenital diseases in humans, as well as our understanding of the pathogenesis
of certain adult disease states. Furthermore, elucidation of the molecular
foundations of developmental biology has been a guiding force directing inroads
into the nascent field of regenerative medicine.
At the heart of any molecular understanding of developmental processes
lies the biology of the progenitor cell. It is impossible to understand how an organ
develops and is remodeled in utero or how a tissue can be engineered and
manipulated ex vivo without first understanding the factors directing the behavior
of individual progenitor cells. This introductory chapter focuses on our increasing
understanding of how progenitor cell behavior is regulated at the molecular level,
and, in particular, at the level of the transcriptome. Transcriptional regulation in
progenitor cells is discussed in the specific context of murine neural crest cell
biology.

Extrinsic and intrinsic regulation of progenitor cell behavior
The central dogma of gene expression states that a cellʼs transcriptome is
determined by the primary sequence of DNA that comprises its genome.
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However, this dogma lies at odds with the basic premise of developmental
biology, in which different progenitor cells, each possessing the same genomic
sequence, diversify and exhibit vastly different transcriptional profiles.
As has become clear from molecular investigations into progenitor cell
biology, external stimuli play an enormous role in influencing each progenitor
cellʼs transcriptome, identity, and characteristics. For instance, the Notch
signaling cascade, a direct cell-cell communication pathway, is a classical
initiator of cellular differentiation in multiple developmental contexts (Andersson
et al., 2011). Progenitor cells primed to receive Notch signals undergo
transcriptional changes in response to Notch stimulation; these changes are
mediated by the canonical downstream effector molecule of Notch signaling, the
transcription factor NICD (Andersson et al., 2011). Similarly, the canonical Wnt
signaling pathway, a paracrine signaling modality, has been shown in multiple
settings to be critical for regulating the expansion of progenitor cell populations,
again through a process mediated by nuclear translocation of a downstream
effector molecule/transcription factor, ß-catenin (Klaus and Birchmeier, 2008). To
be sure, numerous other signaling pathways and environmental stimuli have
been shown to regulate countless aspects of progenitor cell behavior in many
developmental processes. The influence of such external stimuli comprises a
crucial, extrinsic level of regulation over the progenitor cell transcriptome, and
offers insight into how cells with identical genomes can exhibit phenotypic
differences.
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However, despite their obvious importance, environmental triggers cannot
account for all aspects of progenitor cell behavior. From the earliest
transplantation studies, it has been appreciated that not all progenitor cells are
equal; for instance, a neuronal progenitor cell will not differentiate into a
cardiomyocyte if introduced into primary heart field, even if exposed to all of the
environmental cues that normally drive cardiomyocyte differentiation. Clearly,
there are additional levels of regulation at play – cell intrinsic processes that
define a progenitor cellʼs competency to respond to specific external stimuli, as
well as its ability to propagate information from such stimuli to its progeny, even
after the stimulus is withdrawn. Many of these intrinsic processes fall into the
realm of epigenetics.

Histone

deacetylases

and

epigenetic

regulation

of

gene

expression
The field of epigenetics is comprised of the study of factors that stably
affect transcription in a cell and its progeny without altering the sequence of DNA.
Such factors can include long-lasting changes to the structure of chromatin that
affect transcription at specific loci. In the operational definition of epigenetics
proposed by Berger et al., epigenetic processes begin with an epigenator – a
signal, from either environmental or intracellular origin that results in activation of
an epigenetic initiator (Berger et al., 2009). These initiators are responsible for
translating a signal from the epigenator into an alteration to chromatin structure
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or accessibility. Finally, this chromatin alteration must be maintained by an
epigenetic maintainer. This maintainer confers longevity and heritability to
chromatin alterations even in the absence of continued stimuli from the
epigenator.
Classic epigenetic maintainers include covalent modifications to either
DNA itself or to histone proteins. Histone modifications, including histone tail
methylation or acetylation, affect the structure of chromatin, thereby affecting the
ability of transcription factors and other nuclear proteins to bind to promoter or
enhancer regions. These modifications persist through DNA replication, and
thereby confer stability through multiple cell divisions.
Acetylation occurs on at least 12 different lysines in the H3 and H4 histone
proteins (Wang et al., 2008). Histone tail acetylation is generally associated with
transcriptionally active chromatin, as characterized by RNA Polymerase II binding
(Wang et al., 2009). Negatively charged acetyl groups repel DNA from histone
proteins, creating a ʻrelaxed,ʼ euchromatic state, disrupting higher order
chromatin structures, and permitting access to transcription factors and RNA
Polymerase II (Wade et al., 1997). In a second mechanism by which histone
acetylation status affects transcription, acetylated lysines serve as a binding
substrate for bromodomain-containing transcription factors, resulting in RNA
Polymerase II recruitment (LeRoy et al., 2008). Histone tail acetylation is tightly
regulated by the antagonistic actions of histone acetyltransferases, such as
p300, and histone deacetylases (Hdacs).
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Mammals express 11 ʻclassicʼ Hdac proteins, characterized by a highly
conserved deacetylase domain. The canonical role of the aptly named Hdacs is
to deacetylate histone tails. As such, Hdacs are viewed primarily as
transcriptional repressors (Haberland et al., 2009b). These 11 proteins are
subdivided into four classes based on homology (Haberland et al., 2009b). The
class I Hdacs - Hdac1, Hdac2, Hdac3 and Hdac8 - are important regulators of
transcription, via chromatin-mediated transcriptional repression and, in some
cases, via direct deacetylation of key transcriptional regulators (Haberland et al.,
2009b, Haberland et al., 2009a, LeBoeuf et al., 2010). Hdac enzymatic activity is
dependent on their association with large repressor complexes, such as the
NuRD, CoREST or Sin3 complexes, which interact with Hdacs 1 and 2, and the
NCoR and/or SMRT repressor complexes, which interact with Hdac3 (Yang and
Seto, 2008). Hdacs do not possess intrinsic DNA binding ability, and are targeted
to specific genomic loci through their interaction with corepressors, transcription
factors and nuclear receptors (Yang and Seto, 2003).
Deletion studies of individual class I Hdacs have revealed highly specific,
non-redundant roles in various mammalian cell lineages. For instance, despite
widespread expression, global deletion of Hdac2 results predominantly in cardiac
abnormalities, while global deletion of Hdac8 solely affects patterning of the
anterior calvarium and viscerocranium (Trivedi et al., 2007, Haberland et al.,
2009a). It was initially somewhat surprising that deletion of these global
modulators of gene expression lead to dysregulation of specific pathways, rather
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than to non-specific, ectopic upregulation of transcription. Perhaps equally
surprisingly, tissue specific deletion studies have also revealed that an individual
Hdac can mediate completely different processes either in different tissues or
under different environmental conditions within the same tissue. The many roles
played by class I Hdacs during development typify this tissue- and contextdependency of Hdac function.

Class I Hdacs in development
Many epigenetic initiators, including class I Hdacs, have been shown to
modulate transcription during development by linking the external environment
encountered by progenitor cells to heritable changes in gene expression. Class I
Hdacs are widely expressed during mammalian development and play very
specific roles in both early developmental processes as well as later stages of
embryogenesis. Global deletion of Hdac1 or Hdac3 results in early embryonic
lethality, and therefore many of the approaches used to study the role of class I
Hdacs in development have made use of Cre recombinase, driven under the
control of tissue-specific promoters, to excise floxed alleles of Hdac genes	
  
(Montgomery et al., 2007, Knutson et al., 2008).
Conditional deletion studies have revealed that Hdac1 and Hdac2 are
functionally redundant in many tissues, and tissue-specific compound deletion of
both results abnormalities in a variety of systems. For instance, deletion of Hdac1
and Hdac2 in embryonic epidermal progenitor cells results in impaired
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specification of hair follicles and decreased epidermal stratification (LeBoeuf et
al., 2010). Hdac1 and Hdac2 regulate epidermal development by working
cooperatively with p63 and by directly deacetylating p53 in order to repress cell
cycle inhibitors (LeBoeuf et al., 2010). Conditional deletion of Hdac1 and 2 in the
developing nervous system has revealed critical, redundant roles in neuronal
differentiation, oligodendrocyte differentiation, and myelination (Montgomery et
al., 2009, Ye et al., 2009, Jacob et al., 2011). In the heart, Hdac1 and 2 act
redundantly

to

regulate

proliferation

and

contractility

of

developing

cardiomyocytes. Additionally, Hdac2 is important in mediating the adult heartʼs
hyertrophic response to pressure overload, in part by repressing the regulatory
enzyme Inpp5f (Trivedi et al., 2007, Zhu et al., 2009).

Hdac3 as a unique class I Hdac
Hdac3 is a 49 kilodalton class I Hdac most similar in homology to Hdac8
(Haberland et al., 2009b). However, Hdac3 is unique among class I Hdacs in that
it associates with NCoR or SMRT in a repressor complex, which is required for its
catalytic activity (Guenther et al., 2001). Global deletion of Hdac3 in the mouse
results in lethality at the gastrulation stage (Knutson et al., 2008). Hdac3 has
been shown to regulate a variety of cellular processes, which are highly
dependent on the type of tissue under investigation, as well as factors such as
the nutritional state or developmental stage of the tissue. For instance, Hdac3
has been shown to mediate differentiation in osteoblast and myocyte precursors
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in vitro (Schroeder et al., 2004, Zeng et al., 2006); Hdac3 has been shown to
regulate cell cycle progression in cell lines and cardiomyocytes (Li et al., 2006,
Bhaskara et al., 2008, Montgomery et al., 2008, Knutson et al., 2008, Trivedi et
al., 2008); Hdac3 also plays important roles in metabolic regulation in multiple
tissues, including the heart, through its action as a transcriptional repressor
(Montgomery et al., 2008, Sun et al., 2011, Knutson et al., 2008, Alenghat et al.,
2008).
As with other Hdacs, the functions of Hdac3 as a global agent of chromatin
remodeling are determined by its genomic binding sites. Interestingly, ChIP-Seq
studies have revealed that genomic localization of Hdac3 demonstrates very little
overlap between different cell types, which is consistent with its broadly different
functions in different tissues (Feng et al., 2011). Within each cell type, the Hdac3
repressor complex is targeted to different genomic loci by transcription factors or
nuclear receptors expressed in that cell (Feng et al., 2011). Hdac3 has been
shown to interact directly with transcription factors such as Zfp521 in osteoblast
precursors and PPARα in cardiomyocytes, in order to mediate its functions as a
chromatin-remodeling enzyme (Hesse et al., 2010, Montgomery et al., 2008).
Recent evidence suggests that as little as one factor may influence the majority
of Hdac3 binding sites within a given tissue. In the liver, where Hdac3 is an
important regulator of the circadian expression of metabolic genes, Hdac3
binding specificity is predominantly determined by the nuclear receptor Rev-erbα
(Feng et al., 2011). Rev-erbα directly associates with the Hdac3/NCoR complex
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and is crucial for Hdac3-mediated transcriptional repression in hepatocytes. In
fact, nearly all Hdac3 binding sites in hepatocytes, as determined by ChIP-Seq,
overlap with Reverb-alpha binding sites. The abundance of Rev-erbα in
hepatocytes is itself regulated by the metabolic state of the cell and circadian
clock, resulting in a circadian oscillatory pattern to Rev-erbα nuclear localization.
This periodicity results in a circadian pattern to Hdac3 genomic localization and
function in the liver, offering an example of a contextual specificity to the function
of Hdac3 within one cell type (Feng et al., 2011).
Clearly the functions of Hdac3 within a given tissue can be regulated by the
expression and availability of its specific interacting partners within that tissue, as
well as by related factors such as the nutritional state and zeitgeber time.
However, little is known about how the functions of Hdac3 change within a
specific tissue during other important biological transitions, including during
organogenesis.

Hdac3 in cardiac development and homeostasis
The study of Hdac3 in the heart provides an example of the diverse,
context-dependent functions of this important regulatory molecule from early
development to adult homeostasis. Cardiac development is characterized by the
gradual lineage restriction of multiple progenitor cell populations, a process tightly
linked to the emergence of a three-dimensional organ of progressively increasing
morphological complexity. In normal cardiac development, mesodermally-derived
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bipotent myocardial progenitor cells in the cardiac crescent undergo progressive
lineage restriction, ultimately giving rise to either vascular smooth muscle
precursors or myocardial progenitor cells (Epstein, 2010). Myocardial progenitor
cells further differentiate, giving rise to immature cardiomyotytes, as well as other
specialized cardiac cell types. These immature cardiomyocytes form a
spontaneously beating single-chambered tube, which begins to circulate blood
into the developing vascular network of the embryo. As this primitive heart tube
beats, it loops upon itself, forming a two-chambered organ with a single atrium
and ventricle, populated by phenotypically distinct atrial and ventricular myocytes.
These processes occur in parallel with development of the outflow tract,
discussed in detail in Chapter 3. Emybronic ventricular myocytes lack the
plasticity of myocardial progenitor cells but differ from adult cardiomyocytes in a
number of regards. Embryonic cardiomyocytes express different contractile
proteins than their adult counterparts, and exhibit high proliferative potential. As
the two-chambered heart grows, driven by myocyte proliferation, the single
ventricular chamber is septated, a process dependent on neural crest cells
(further discussed in Chapter 3). In late gestation and early in the perinatal
period, cardiomyocytes mature, a process characterized by alterations to their
mechanical and electrophysiological properties and their decreased proliferative
and regenerative potential (Porrello et al., 2011).
Hdac3 acts at multiple stages in the transition from bipotent myocardial
progenitors to embryonic and, ultimately, adult cardiomyocytes. Unpublished data
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generated by Trivedi et al. in the Epstein lab shows that deletion of Hdac3 at
embryonic day 8.5 (E8.5) in biopotent myocardial progenitor cells results in
severe myocardial thinning and lethality by E16.5. These cardiac abnormalities
arise due to cell cycle arrest and decreased proliferation of embryonic
cardiomyocytes. This cell cycle arrest is accompanied by upregulation of the cell
cycle inhibitor p21 (encoded by the Cdkn1a gene). Preliminary results suggest
that heterozygous deletion of Cdkn1a in mutant embryos partially rescues the
early cardiac lethality, with a small number of mutants surviving until birth. Hdac3
has previously been shown to inhibit Cdkn1a transcription by directly binding to
its promoter (Wilson et al., 2008); derepression of Cdkn1a in the absence of
Hdac3 may therefore play a critical role in mediating the lethality following early
cardiac deletion of Hdac3.
In addition to derepression of Cdkn1a, loss of Hdac3 in these mice leads to
premature expression of markers of differentiated cardiomyocytes in vivo, and
deletion of Hdac3 in cultured E8.5 myocytes leads to precocious differentiation
and

spontaneous

beating

in

vitro.

Preliminary

data

from

chromatin

immunoprecipitation experiments has revealed that Hdac3 directly binds to the
promoter regions of cardiac-specific genes in E8.5 hearts, suggesting that it may
serve as a direct repressor of cardiomyocyte differentiation in bipotent myocardial
progenitor cells. Overall, these results suggest that Hdac3 directly represses
mediators of myocardial differentiation as well as the cell cycle inhibitor p21;
following early deletion of Hdac3, the myocardial progenitor cells pool is therefore
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depleted via a combination of premature differentiation and cell cycle arrest,
leading to severe cardiac abnormalities later in gestation.
A study by Olson and colleagues has shown that deletion of Hdac3 slightly
later in cardiac development, at E9.5 using αMHC-Cre, allows for the completion
of

embryogenesis.

αMHC-Cre

mediates

recombination

in

differentiated

cardiomyocytes, rather than bipotent precursors. αMHC-Cre; Hdac3f/f mice are
viable until two months of age; however, when fed a normal diet, these mice
undergo cardiac hypertrophy at 4 weeks of age, which progresses to severe
heart failure, culminating in lethality. This hypertrophy is characterized by
myocardial lipid accumulation and fibrosis. The authors suggest that, following
midgestational deletion of Hdac3, positive regulators of fatty acid uptake are
derepressed, leading to progressive accumulation of lipid in the myocardium and
eventual cardiac dysfunction and death.
In a collaborative effort with the Lazar lab, we have demonstrated that
deletion of Hdac3 in perinatal myocytes - as opposed to bipotent progenitor cells
or embryonic ventricular myocytes – results in dysregulation of a vastly different
subset of genes than those dysregulated following mid-gestational deletion (Sun
et al., 2011). In this study, mice lacking cardiac expression of Hdac3 show
dysregulation of genes involved in the mitochondrial response to lipid overload.
They exhibit no decrease in viability on a normal diet; however, when placed on a
high fat diet, they exhibit severe cardiac defects leading to death. These data are
summarized in the Appendix. These contrasting conditional deletion studies in
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which Hdac3 has been deleted in the heart during midgestation versus in the
perinatal period demonstrate that Hdac3 plays distinct roles in metabolic
regulation at embryonic versus postnatal timepoints; furthermore, the time point
at which Hdac3 is deleted in cardiomyocytes portends the long-term
transcriptional perturbations that persist into adulthood.
Overall, these cardiac studies have revealed multiple roles for Hdac3 within
a single cell lineage; Hdac3 inhibits differentiation down the cardiomyocyte
lineage in bipotent myocardial precursors, represses genes involved in lipid
metabolism in embryonic myocytes, and regulates different genes involved in the
response to lipid overload in postnatal cardiomyocytes (Figure 1.1). Based on its
roles in mediating developmental processes as well as cellular responses to
environmental stimuli in the heart, Hdac3 is an attractive candidate epigenetic
initiator that could integrate input from exogenous cues and regulate important
developmental processes in a stage- and lineage-specific manner in other
multipotent progenitor cells under complex regulation from external stimuli.

Neural crest development
Neural crest cells comprise a transient embryonic progenitor cell
population, specific to vertebrates, that provides a useful model for studying
progenitor cell specification, migration and differentiation in the context of the
development of multiple tissues and organ systems. Neural crest cells are
derived from ectoderm and are specified at the dorsal neural tube at E8.5 in the
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mouse. They subsequently undergo epithelial to mesenchymal transformation
(EMT), delaminate from the neural tube and migrate throughout the embryo.
They ultimately give rise to transient embryonic structures including the
mesenchyme of the pharyngeal arches, as well as structures that persist in the
adult vertebrate, including much of the smooth muscle of the cardiac outflow
tract, much of the bone, cartilage and connective tissue of the head and face,
neurons and support cells of the peripheral nervous system, and the chromaffin
cells of the adrenal medulla (Figure 1.2).
Neural crest cells develop in a dynamic milieu, under the influence of
environmental cues that regulate many aspects of their behavior. Though little is
known about the signals that direct the specification of murine neural crest cells,
environmental cues that drive neural crest migration, survival and differentiation
in the mouse are well understood (Sauka-Spengler and Bronner-Fraser, 2008).
Changes to the extracellular matrix help to initiate EMT, while ephrin and
semaphorin-neuropilin signaling from surrounding cells have been implicated in
neural crest cell migration through the somitic mesoderm (Sauka-Spengler and
Bronner-Fraser, 2008, Davy et al., 2004, Gammill et al., 2007). As well,
numerous signals encountered by both migrating and postmigratory neural crest
cells direct their survival and differentiation (discussed further in Chapter 2 and
Chapter 3). While much is now known about the signaling modalities that
influence murine neural crest cell behavior, we are only beginning to understand
how neural crest cells are able to synthesize these signals into heritable changes
	
  
15	
  

in gene expression, and how individual neural crest cells initially become
competent to respond to these exogenous cues.

Epigenetic regulation of neural crest development
Neural crest cells are characterized by enormous developmental plasticity.
However, it has long been appreciated that, from very early stages of neural crest
development, there is in-equivalency between certain neural crest cells. Studies
in which quail neural crest cells were transplanted into chick embryos have
revealed the remarkable degree to which neural crest cells from one region along
the rostro-caudal axis of the embryo can contribute to derivatives of another
region - with some exceptions. Among the exceptions uncovered by Le Douarin
and colleagues in a classic series of experiments; neural crest from the vagal
region, which normally contributes to rostral elements of the enteric nervous
system, was transplanted into the adrenomedullary trunk crest region, which
normally gives rise to the adrenal medulla, sympathetic ganglia and the enteric
plexi of the distal bowel. In this study, vagal neural crest cells were able to
contribute to all derivatives of the adrenomedullary crest, with the exception of
the distal enteric nervous system, to which they were unable to migrate (Le
Douarin et al., 1975) . This limit on vagal trunk neural crest plasticity suggests
that, in addition to being subject to external influences on their development,
undifferentiated neural crest cells are subject to an intrinsic level of regulation.
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Recent work has focused on understanding the nature of this intrinsic regulation
of neural crest cell behavior.
Neural crest migration is regulated by the expression of transcription
factors such as Sox10 and Ret in response to environmental cues. Mutations in
these genes have been implicated in Hirschprungʼs disease in humans, in which
failure of neural crest cells to migrate to the distal gut and differentiate into enteric
ganglia leads to defects in colonic motility. Recently, Aebp2, a targeting protein
for the Polycomb Repression Complex 2 (a regulatory complex involved in
transcriptional regulation via histone methylation), was shown to regulate the
expression of several transcription factors that mediate neural crest cell
migration. Mice haploinsufficient for Aebp2 demonstrate aganglionic megacolon,
due to failure of neural crest cells to migrate to the distal enteric nervous system
(Kim et al., 2011). The migration of neural crest cells into the distal gut is a
process that, as early as 1975, was hypothesized by LeDourain and colleagues
to be under cell intrinsic regulation; this study of an important chromatin
remodeling complex has now shown that it is indeed regulated at an epigenetic
level.
Additional attempts to determine which factors underlie intrinsic regulation
of neural crest first focused on genes such as Hox family members, which have
been shown to restrict cranial neural crest cell plasticity during skull
morphogenesis (Hunt et al., 1991). More recently, as the field has moved
towards studies of chromatin remodeling enzymes that regulate neural crest
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development, one of the first such studies in the mouse revealed a connection
between epigenetic processes and expression of Hox genes in craniofacial
development. Olson and colleagues showed that Hdac8 normally restricts the
expression of Hox family members in the anterior cranium during development,
and that deletion of Hdac8 leads to ectopic Hox gene activation (Haberland et al.,
2009a). They further demonstrated that global deletion of Hdac8, as well as
tissue specific deletion in neural crest, results in calvarial instability, leading to
perinatal lethality (Haberland et al., 2009a).
Transcriptional regulation via chromatin remodeling complexes has thus
far been implicated in a limited number of aspects of neural crest development.
Identifying additional chromatin remodeling enzymes that control other aspects of
neural crest development - and deciphering the transcriptional networks that they
regulate - will be a fruitful and important area of research as we seek to
understand how progenitor cells are regulated at the epigenetic level.

Conclusions
An emerging body of work has implicated chromatin-modifying enzymes in
the regulation of important processes and transitions during the development of
multiple progenitor cell populations, including neural crest. Class I Hdacs have
been recognized as important regulatory enzymes in many developmental
contexts; Hdac3 in particular has been shown to regulate developmental
processes in a growing number of organ systems, and offers an appealing
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candidate for further investigation into the intrinsic regulation of neural crest
development.
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No survival decrease on
normal chow!
Lethality at 4 months of age
on high fat diet!
Myocardial lipid
accumulation in the setting of
lipid overload!

Genes involved in the
mitochondrial response to
lipid overload!
Estrogen-related receptor
(ERR) and PGC-1 targets!

Figure 1.1. Hdac3 functions in cardiomyocytes vary during cardiac
development and postnatal homeostasis. A schematic diagram showing the
different functions of Hdac3 in bipotential myogenic precursors, embryonic
ventricular myocytes and perinatal cardiomyocytes, as well as the classes of
genes that are dysregulated in a persistent manner following loss of Hdac3.
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Figure 1.2
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Figure 1.2. Neural crest cell developmental potential is organized along the
rostro-caudal axis. A gross image of an E9.5 embryo under direct fluorescence
in which neural crest cells and their derivatives have been genetically labeled
using Wnt1-Cre and the Z/EG GFP reporter. Labels denote the derivatives of
neural crest cells originating from each region of the dorsal neural tube.
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Chapter 2. Hdac3-mediated repression of Bmp4 in
neural

crest

cells

regulates

murine

craniofacial

development

Summary
Craniofacial development is characterized by reciprocal interactions
between neural crest cells and neighboring cell populations of ectodermal,
endodermal

and

mesodermal

origin.

Various

modalities

of

cell-cell

communication, such as Bmp signaling, play critical roles in coordinating the
development of cranial structures, by modulating the growth, survival, and
differentiation of neural crest cells. However, the regulation of these signaling
pathways, particularly at the epigenetic level, remains poorly understood. In this
chapter I describe the role of Hdac3 in regulating important signaling pathways
and transcriptional networks in craniofacial development.
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Introduction
Vertebrates are unique among metazoans in their reliance on neural crest
cells to form a wide array of structures in the head. These neural crest-derived
craniofacial structures are analogous to mesodermally- and ectodermally-derived
structures in invertebrates (Gans and Northcutt, 1983). In midgestation in the
mouse, neural crest cells populate the pharyngeal arches – a series of paired
outpouchings that flank the developing pharynx, as well as the frontonasal
prominence, an area that eventually gives rise to the nose and forehead. The first
pharyngeal arch, which is the largest and most rostral of the arches, contains
neural crest cells that will form structures in the face and neck (Alappat et al.,
2003). Driven by the proliferation and continued influx of migrating neural crest
cells, two distinct outgrowths from the first arch, known as the maxillary and
mandibular prominences, grow dorso-ventrally and flank the developing
oropharynx, eventually fusing at the ventral midline in what becomes the face.
Failure of neural crest cells to migrate or proliferate appropriately can result in
hypoplasia of these structures and the absence of fusion, which can manifest as
abnormal facies and clefting (Ito et al., 2003, Vallejo-Illarramendi et al., 2009).
While initially dependent on the tightly-regulated growth of undifferentiated
neural crest cells in the prominences, craniofacial development is also reliant on
the ability of neural crest cells to differentiate into bone, cartilage, connective
tissue, dental pulp and neurons that populate the mature face and skull. In the
primordial environment of the growing pharyngeal arches, neural crest cells are
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characterized by enormous developmental plasticity (Couly et al., 1993). In the
setting of such plasticity, the ability of neural crest cells to contribute to such
varied cell types is largely dependent on their exposure to environmental cues
from surrounding cells of both neural crest and non-neural crest origin (Le
Douarin et al., 2004). Indeed, as discussed in Chapter 1, both the survival and
differentiation of neural crest cells are under tight regulation by multiple signaling
modalities.
Murine genetics have proven invaluable in deciphering the exogenous
signals that coordinate the growth and differentiation of cranial neural crest cells.
For instance, models of conditional deletion and overexpression of Bmp4 have
revealed roles for this signaling molecule in various aspects of craniofacial
development. Bmp4 is primarily expressed by epithelial structures in the
developing face, which signal to neural crest-derived mesenchyme to mediate
processes such as palatogenesis and tooth development (Zhang et al., 2002,
Mitsiadis et al., 2010). Interestingly, both abrogation and ectopic activation of
BMP signaling lead to cell cycle dysregulation, cleft palate and tooth
abnormalities, suggesting that this signaling pathway is subject to multiple levels
of regulation in neural crest development (He et al., 2010).
While the correct spatial and temporal expression of signaling molecules is
critical for normal craniofacial morphogenesis, little is known about how the
signaling pathways involved in this process are regulated at the epigenetic level.
Using in vivo and in vitro models, I show in this chapter that the class I histone
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deacetylase Hdac3 regulates important genetic programs and signaling pathways
involved in murine craniofacial development. Genetic deletion of Hdac3 in neural
crest results in microcephaly, cleft palate, ossification defects and other
craniofacial abnormalities in late gestation. Consistent with these observations,
we observe dysregulation of mediators of craniofacial development in
midgestation following loss of Hdac3, including transcription factors belonging to
the Msx and Tbx families. We show that this aberrant gene expression is
mediated, in part, by derepression of Bmp4 in neural crest. These results suggest
that Hdac3-mediated repression of Bmp4 plays a critical role in craniofacial
development.
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Results

Hdac3 is expressed during embryogenesis and is efficiently deleted in
premigratory neural crest cells by Wnt1-Cre
Immunohistochemistry of staged embryos demonstrates that Hdac3 is
widely expressed at E10.5, including in the dorsal neural tube, where neural crest
cells are specified before delaminating and migrating throughout the embryo
(Figure 2.1 A). Hdac3 is also expressed by neural crest derivatives, including
dorsal root ganglia (DRG) and cranial mesenchyme (Figure 2.1 A,B).
The Wnt1-Cre transgene is expressed by premigratory neural crest cells
as early as E8.75 (Jiang et al., 2000). We used Wnt1-Cre and a floxed Hdac3
allele (Hdac3f) to delete Hdac3 in premigratory neural crest cells and their
derivatives, and we used the Z/EG reporter to lineage trace neural crest cells in
both control and mutant embryos (Feng et al., 2011, Novak et al., 2000). In this
lineage tracing strategy, Cre mediates a recombination event that results in the
constitutive expression of GFP in all derivatives of Wnt1-Cre-expressing cells.
Immunostaining for GFP reveales expression in the dorsal neural tube in both
Wnt1-Cre; Hdac3f/f (termed Hdac3Wnt1NCKO); Z/EG and Wnt1-Cre; Z/EG control
embryos (Figure 2.1 A). In E10.5 Hdac3Wnt1NCKO embryos, the GFP-positive cells
in the dorsal neural tube show loss of Hdac3 protein, indicating efficient Cremediated recombination in neural crest (Figure 2.1 A). Lineage tracing analysis
further demonstrates that neural crest cells populate the DRG, pharyngeal arches
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and cranial mesenchyme in E9.5 and E10.5 Hdac3Wnt1NCKO; Z/EG embryos,
despite efficient deletion of Hdac3 in these tissues (Figure 2.1 A-C).
Immunohistochemistry also reveals that Hdac3 deletion is specific to neural
crest-derived mesenchyme, while expression is retained in ectoderm and
endoderm (Figure 2.1 C). However, despite grossly intact neural crest cell
specification and migration in the absence of Hdac3, marked hypoplasia of the
neural crest-derived maxillary and mandibular prominences of the first
pharyngeal arch is apparent by E10.5 in Hdac3Wnt1NCKO embryos (Figure 2.1
C,D).

Hdac3Wnt1NCKO embryos exhibit severe craniofacial abnormalities in late
gestation, resulting in perinatal lethality
Hdac3Wnt1NCKO embryos are found at expected Mendelian ratios in late
gestation and are viable until birth (Table 2.1). However, these mice uniformly
succumb at P0 (Table 2.1). Hdac3Wnt1NCKO mice are born with microcephaly,
micrognathia, a shortened snout and eyelid closure defects, with preservation of
body morphology (Figure 2.2 A). Optical projection tomography and histology of
Hdac3Wnt1NCKO heads reveals cleft palate, which is also apparent in late gestation
embryos (Figure 2.2 B,C). The palate defect is characterized by a large posterior
cleft without additional facial clefting (Figure 2.2 B). Cleft palate is fatal in
perinatal mice; afflicted pups are unable to generate suction and nurse, and
subsequently die at P0 from dehydration and accumulation of air in the digestive
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tract (Qiu et al., 1995, Condie et al., 1997). Consistent with these reports,
Hdac3Wnt1NCKO pups are unable to feed, as evidenced by the lack of a milk spot
(Figure 2.2 A). The gross craniofacial defects observed in Hdac3Wnt1NCKO mice
are fully penetrant and are summarized in Table 2.2. We observed similar
craniofacial abnormalties using a second neural crest driver, Pax3Cre (Engleka et
al., 2005); these abnormalities are also evident both at P0 and in late gestation
(Figure 2.3).

Loss of Hdac3 leads to ossification defects in the calvarium and
viscerocranium
In the adult vertebrate, osteoblasts are among the most abundant cell
types generated by cranial neural crest. Neural crest-derived osteoblasts
contribute to the bones of the face, the skull base and the entirety of the
calvarium, with the exception of the parietal bone (Santagati and Rijli, 2003).
Hdac3 has previously been implicated in multiple stages of osteoblast
differentiation and maturation. In committed, undifferentiated osteoblasts that
express the Osx-Cre transgene, deletion of Hdac3 leads to subtle abnormalities
in calvarial osteoblast differentiation, and progressive abnormalities in trabecular
bones that lead to perinatal runting, and death early in adulthood (Razidlo et al.,
2010). While these findings demonstrate a role for Hdac3 in promoting bone
formation, in both perinatal osteoblasts and in the MC3T3 cell line, Hdac3 inhibits
the pro-osteogenic effects of Runx2, suggesting that Hdac3 is playing an anti	
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osteogenic role in a slightly later stage of bone development (Schroeder et al.,
2004, Hesse et al., 2010). In more mature osteoblasts, marked by RANKL
expression, Hdac3 inhibits the anti-osteogenic effects of Runx2, resulting in a net
pro-osteogenic role once again (Hesse et al., 2010).
Consistent with a pro-osteogenic role for Hdac3 in the earliest stages of
bone development, Hdac3Wnt1NCKO mice - in which Hdac3 is deleted well before
osteoblasts are specified (before the onset of Osx-Cre expression) - exhibit
severe bone defects in the calvarium and viscerocranium. Alcian blue/alizarin
red staining of the late embryonic and perinatal heads reveales decreased
ossification of the calvarium, particularly in the region of the frontal bone, where
ossified bone is undetectable by alizarin red staining (Figure 2.4 A). The open
frontal fontanel leads to hemorrhage in some newborn pups following parturition
(Figure 2.2 B). The parietal bone develops normally in Hdac3Wnt1NCKO mutants,
consistent with its mesodermal origin (Figure 2.2B). In mutant embryos,
ossification abnormalities of the viscerocranium were also identified in the
mandible, skull base and tympanic ring (Figure 2.4 A).
Additional bone abnormalities in E17.5 mutant embryos are detected by
Goldnerʼs trichrome staining. Neural crest-derived calvarial bones, including the
frontal bone, are thin and show minimal mineralization (Figure 2.4B). Additionally,
at variable penetrance, absence of ossification in the cribiform plate results in
encephalocoele, in which the brain herniates into the nasal sinuses (Figure 2.4
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B). The ossification defects observed in Hdac3Wnt1NCKO mice are summarized in
Table 2.2.
We used an ex vivo approach to identify important regulators of
ossification that are dysregulated following the loss of Hdac3. We grew cranial
mesenchyme isolated from mutant and littermate controls in culture and found
that Runx2, a critical regulator of ossification, and alkaline phosphatase, a marker
of differentiating bone, are significantly downregulated in mutant cultures (Figure
2.4 C). We subsequently found that Runx2 expression in the developing
calvarium and skull base is decreased in vivo at E12.5 (Figure 2.4 D). The Runx2
expression domain is diminished in spite of the presence of large numbers of
neural crest cells in these regions in the mutant (Figure 2.4 D). These results
suggest that downregulation of Runx2 in neural crest cells is an important
mechanism by which ossification defects develop in Hdac3Wnt1NCKO embryos.

Abnormal odontogenesis in the absence of Hdac3 leads to dental
hypoplasia
In tooth development, signals from the epithelium initiate condensation of
neighboring neural crest cells at E11.5 (Chen et al., 2000). As epithelial cells
invaginate, they envelop neural crest cells, which will eventually form the pulp of
the tooth (Figure 2.5 A). The early stages of odontogenesis proceed normally in
Hdac3Wnt1NCKO embryos, with tooth bud morphology at E15.5 appearing similar to
littermate controls (Figure 2.5 A-D). However, expansion of the neural crest	
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derived mesenchyme does not occur between E15.5-E17.5, resulting in
hypolastic teeth with the absence of normal pitting (Figure 2.5 E,F). The tooth
bud hypoplasia in mutant embryos parallels the hypoplasia observed in other
neural crest-derived structures in late gestation (Figure 2.2).

Aberrant cell cycle regulation in Hdac3-deficient cranial mesenchyme
leads to cleft palate and microcephaly
In order to determine the mechanism of cleft palate in Hdac3Wnt1NCKO
embryos, we performed a histological analysis of staged control versus mutant
embryos. In normal palatogenesis, the anterior palate (referred to as the primary
palate) is formed by the initial fusion of the maxillary prominences with the
frontonasal prominence. Hdac3Wnt1NCKO embryos exhibit posterior cleft palate,
suggesting that secondary palatogenesis is disrupted (Figure 2.2 B). The
posterior aspects of the hard palate (referred to as the secondary palate) are
formed from two outgrowths of neural crest-derived mesenchyme that lie on
either side of the stomodeum (primitive mouth). These outgrowths are referred to
as the palatal shelves, and are detectable at E11.5 in the mouse (Figure 2.6 A).
Between E11.5 and E13.5, the palatal shelves, driven by neural crest cell
proliferation, expand towards the mandible (Figure 2.6 A,B). Between E13.5 and
E14.5, the palatal shelves elevate relative to the tongue and fuse in the midline
with the nasal septum (Figure 2.6 C). This newly formed structure subsequently
ossifies, giving rise to the secondary palate.
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Disruption of any of the stages of secondary palatogenesis - palatal shelf
formation, expansion, elevation, fusion or ossification – can lead to cleft palate in
mice, and similar mechanisms can contribute to secondary cleft palate in humans
(Richarte et al., 2007, Ito et al., 2003, Vallejo-Illarramendi et al., 2009, He et al.,
2011, Wu et al., 2008). Histological analysis of Hdac3Wnt1NCKO embryos reveals
that the palatal shelves form appropriately but are hypoplastic at E12.5 (Figure
2.6 E,F). Despite appropriate elevation of the medial aspect of the palatal shelves
by E14.5, they do not meet at the midline (Figure 2.6 G). These results suggest
that cleft palate results in Hdac3Wnt1NCKO embryos due to a failure of palatal shelf
expansion.
Expansion of the palatal shelves is dependent on proliferation and survival
of the neural crest cells that make up the palatal shelf mesenchyme (Ito et al.,
2003). In E12.5 control versus mutant palatal shelves that were matched for
surrounding anatomical landmarks, we detected a significant increase in
apoptosis and a trend towards decreased proliferation, as determined by Tunel
and phospho-histone H3 staining, respectively (Figure 2.6 I). Increased Tunel
staining is also visible throughout additional cranial neural crest-derived
structures outside of the palatal shelf region, suggesting that hypoplasia of these
structures is also mediated by increased apoptosis (Figure 2.6 I and data not
shown).
To discern the nature of the cell cycle dysregulation in Hdac3Wnt1NCKO
cranial mesenchyme, we performed expression profiling by quantitative RT-PCR
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in the anterior cranial region of mutant embryos and littermate controls (Figure
2.6 J). While Hdac3 expression in mutant tissue is significantly downregulated,
expression of additional class I Hdacs is unchanged (Figure 2.6 K). Strikingly, the
expression of multiple cell cycle regulators was found to be altered in
Hdac3Wnt1NCKO cranial mesenchyme. Cdkn1a (p21), Trp52 (p53), Ccnd1c (p57),
Ccnd1 (Cyclin D1), Ccnd3 (Cyclin D3), CcnG1 (Cyclin G1) and Cdk2 are
significantly upregulated in the absence of Hdac3, while Cdkn2c (p18) expression
is downregulated (Figure 2.6 L).
Hdac3 has previously been shown to directly repress the cell cycle
inhibitor p21 in multiple tissues (Wilson et al., 2008, Trivedi et al., 2008). In order
to determine whether the substantial upregulation of p21 observed in
Hdac3Wnt1NCKO cranial mesenchyme could alone account for cleft palate and
microcephaly in these embryos, we deleted Hdac3 in neural crest on a p21 null
background (Deng et al., 1995). Homozygous p21-/- mice develop normally and
are viable and fertile (Deng et al., 1995). We found that loss of p21 does not
rescue the cleft palate and microcephaly observed in Hdac3Wnt1NCKO embryos,
suggesting that dysregulation of additional cell cycle modulators contributes to
altered regulation of neural crest expansion in Hdac3-deficient cranial neural
crest cells and, ultimately, to cleft palate and craniofacial hypoplasia (Figure 2.7).

The loss of Hdac3 results in dysregulation of core transcriptional networks
that regulate craniofacial development
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Multiple families of transcription factors have been implicated in neural
crest cell cycle regulation in craniofacial development. We undertook a candidate
approach to identify whether loss of Hdac3 results in misexpression of known
regulators of cranial crest expansion and survival. Msx1 and Msx2 are expressed
in the cranial mesenchyme, and are known to modulate the cell cycle during
palatogenesis, viscerocranial morphogenesis, and tooth development (Alappat et
al., 2003). We observed marked upregulation by quantitative RT-PCR of Msx1,
Msx2 and Msx3, in E12.5 mutant cranial mesenchyme (Figure 2.8 A). Msx family
members promote apoptosis in neural crest cells, and their upregulation is
consistent with the cell cycle dysregulation and increased apoptosis in
Hdac3Wnt1NCKO

mice

(Alappat

et

al.,

2003).

Interestingly,

transgenic

overexpression of Msx2 leads to cleft secondary palate, micrognathia, tooth
hypoplasia and eyelid dysplasia due to increases in cell death, which
phenocopies many aspects of the Hdac3Wnt1NCKO abnormalities (Winograd et al.,
1997).
In addition to upregulation of Msx family members, we also observed
significant upregulation of the Tbx family members Tbx2 and Tbx3 (Figure 2.8 A).
Tbx2 and Tbx3, like Msx1 and Msx2, are normally expressed in neural crestderived cranial mesenchyme and are similarly important in cell cycle regulation
during palatogenesis (Zirzow et al., 2009). Loss of Tbx2 or Tbx3 in craniofacial
development leads to cleft palate due to excessive proliferation, and both
proteins have been identified as inhibitors of the cell cycle in palatogenesis
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(Zirzow et al., 2009). Overall, upregulation of these Msx and Tbx family members
– known inhibitors of neural crest survival - is consistent with the increased
apoptosis and cell cycle dysregulation observed in Hdac3Wnt1NCKO cranial
mesenchyme, and the resultant craniofacial hypoplasia and cleft palate in mutant
embryos.

Increased expression of Bmp4, a critical regulator of craniofacial
development, in Hdac3Wnt1NCKO cranial mesenchyme
Hdac3 is a global agent of gene repression and has previously been
shown to directly regulate important transcriptional networks in multiple
developmental contexts (Schroeder et al., 2004, Zeng et al., 2006). The
upregulation of Msx and Tbx family members observed in Hdac3Wnt1NCKO
embryos could therefore plausibly occur as a result of their direct transcriptional
derepression in the absence of Hdac3. However, Msx and Tbx family members
have also been implicated in a genetic pathway involving Bmp4, and have been
identified as direct targets of Bmp4 signaling in craniofacial development (Bei and
Maas, 1998, Lee et al., 2007). Bmp4 is expressed predominantly by epithelial
cells, which signal directly to neural crest to regulate palatogenesis and tooth
development (Mukhopadhyay et al., 2006, He et al., 2010, Mitsiadis et al., 2010).
Gain of BMP signaling results in craniofacial abnormalities that partially
phenocopy the abnormalities identified in Hdac3Wnt1NCKO embryos (He et al.,
2010). However, loss of BMP signaling also phenocopies aspects of these
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phenotypes, albeit through different mechanisms (Baek et al., 2011, Mitsiadis et
al., 2010). We detected significant upregulation of Bmp4 expression in the
anterior cranial mesenchyme of E12.5 Hdac3Wnt1NCKO embryos, which is
consistent with the increased apoptosis and the pattern of transcriptional
dysregulation observed in mutant craniofacial mesenchyme (Figure 2.8 A).
In craniofacial development, Bmp4 expression is activated by Sonic
Hedgehog signaling in an autoregulatory loop (Lan and Jiang, 2009, Zhang et al.,
2002). However, little is known about how Bmp4 expression is restricted in the
neural crest. We observed upregulation of Bmp4 in conjunction with a small but
statistically insignificant upregulation of Shh (Figure 2.8 A). These observations
are consistent with a model in which Hdac3 directly represses transcription at the
Bmp4 locus, such that the loss of Hdac3 in neural crest leads to direct
transcriptional derepression.
Based on these findings, we hypothesized that altered Bmp4 expression
in Hdac3-deficient neural crest could account, in part, for the gene expression
profile and phenotypic abnormalities observed in Hdac3Wnt1NCKO embryos. We
used an ex vivo approach to determine the importance of Bmp4 derepression in
mediating the Msx2 upregulation observed in Hdac3-deficient cranial neural
crest. We found that total loss of Hdac3 in E12.5 cultured anterior mesenchymal
cells results in massive cell death (data not shown). Therefore, we induced partial
knockdown of Hdac3 using shRNA, and examined the expression of Bmp4 and
Msx2 in this tissue. We found that partial knockdown of Hdac3 results in a trend
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towards Bmp4 upregulation, and statistically significant upregulation of Msx2
(Figure 2.8 C). This upregulation of Msx2 is abolished by siRNA-mediated
knockdown of Bmp4. These results are consistent with a model in which Hdac3
regulates a Bmp4-Msx2 signaling pathway in cranial neural crest during
craniofacial development.
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Discussion
At multiple stages of neural crest development, the growth and survival of
neural crest cells comes under positive and negative regulation from surrounding
cell types (Sauka-Spengler and Bronner-Fraser, 2008). The signaling molecule
Bmp4 is an important mediator of neural crest apoptosis in both early and late
stages of craniofacial morphogenesis. Delamination of cranial neural crest cells
from the dorsal neural tube requires the programmed death of neural crest cells
at specific levels (rhombomeres) along the rostro-caudal axis. In the chick, Bmp4
is expressed specifically in these rhombomereic levels, both in neural crest cells
themselves and in neighboring ectoderm (Graham et al., 1994). Bmp4 signaling
upregulates Msx2 in order to mediate apoptosis in these populations of neural
crest cells, allowing suriving cells from other rhombomeres to appropriately
populate the developing face (Graham et al., 1994). The mechanism by which
Bmp4 expression is restricted to particular rhombomeric levels is not known.
Excessive Bmp4 signaling in the cranial neural crest in mouse has been shown
to portend abnormal palatal shelf morphology, secondary cleft palate, and dental
hypoplasia (He et al., 2010). These abnormalities are consistent with the
phenotypes caused by Msx2 transgenic overexpression as well as many of the
phenotypes observed in Hdac3Wnt1NCKO embryos (Figure 2.1 C,D, Figure 2.2). It
is therefore intriguing to speculate that Hdac3 could be required to restrict the
expression of Bmp4 in rhombocephalic neural crest. Loss of Hdac3 would
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therefore result in persistent upregulation of Bmp4 in cranial neural crest, leading
to hypoplasia of craniofacial structures.
Both increased and decreased Bmp4 activity in neural crest development
lead to dysregulation of downstream Msx and Tbx transcription factors and
severe craniofacial abnormalities (He et al., 2010, Bei and Maas, 1998). That
craniofacial morphogenesis is so exquisitely sensitive to Bmp4 activity speaks to
the importance of fine regulation of Bmp4 expression in neural crest
development. Our study offers the first evidence of a chromatin remodeling
enzyme playing a role in the regulation of Bmp4 expression. While our data
demonstrate that Hdac3 is required to repress Bmp4 transcription, additional
work is required to discern whether this transcriptional repression is mediated by
direct Hdac3 binding at the Bmp4 locus, or whether this repression is mediated
through intermediates (further discussed in Chapter 4).
In this study we have also identified a distinct role for Hdac3 in promoting
ossification of neural crest-derived bone. This finding is consistent with a proossification role for Hdac3 previously identified in committed osteblast
precursors, although we have found that deletion of Hdac3 prior to commitment
of osteoblasts results far more drastic deficiencies in bone development than
deletion in committed precursors (Razidlo et al., 2010). The mechanism of a proossification role of Hdac3 has not previously been described. In addition to
regulating the Bmp4-Msx pathway, it is likely that Hdac3 regulates a wide range
of other downstream targets in neural crest. While dysregulation of the Bmp4	
  
41	
  

Msx pathway is sufficient to explain many of the craniofacial defects of Hdac3
mutant pups, it is unlikely to contribute to the ossification abnormalities.
Paradoxically, deletion of Msx1 and Msx2 in neural crest leads to heterotopic
bone formation, particulary in the frontal bone region, while Msx2 transgenic
overexpression also results in ectopic bone formation (Roybal et al., 2010, Liu et
al., 1995). This suggests that additional targets of Hdac3 are likely to underlie the
ossification abnormalities in Hdac3Wnt1NCKO mice.
Gene expression analysis of explanted tissue demonstrated that the
critical regulator of ossification Runx2 is significantly downregulated in Hdac3deficient tissue. Hdac3 has not previously been shown to regulate Runx2
expression. However, Hdac3 antagonizes the pro-osteogenic activity of Runx2 in
perinatal osteoblast precursors, while antagonizing the anti-osteogenic activity of
Runx2 in more mature osteoblasts (Schroeder et al., 2004, Hesse et al., 2010).
These diverse roles played by Hdac3 in the regulation of Runx2 in osteogenesis
are reminiscent of the varied functions of Hdac3 in cardiac development and
homeostasis (discussed in Chapter 1). In both organ systems, Hdac3 mediates
vastly different - even antagonistic - processes in different developmental stages
of the same tissue. Determining how the role of Hdac3 is altered during the
course of each tissueʼs development will be an interesting area of future
investigation.
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Materials and Methods

Mice
Wnt1-Cre, Pax3Cre, Hdac3flox and Z/EG mice were maintained on mixed
CD1/B6/129 genetic backgrounds, separated by 3-6 generations of incrossing
from pure parental backgrounds (Jiang et al., 2000, Engleka et al., 2005, Feng et
al., 2011, Novak et al., 2000). p21 null mice were on a pure 129 background
(Deng et al., 1995). Mice were genotyped using previously described Cre-specific
PCR primers (5ʼ-TGC CAC GAC CAA GTG ACA GC-3ʼ, 5ʼ-CCA GGT TAC GGA
TAT AGT TCA TG-3ʼ) (Heidt and Black, 2005), and primers designed to
distinguish between the control and floxed Hdac3 allele (5ʼ-GCA GTG GTG GTG
AAT GGC TT-3ʼ, 5ʼ-CCT GTG TAA CGG GAG CAG AAC TC-3ʼ). Genotyping for
the Z/EG transgene was performed by X-Gal staining tail samples. Littermate
embryos were analyzed in all experiments unless otherwise noted. The
University of Pennsylvania Institutional Animal Care and Use Committee
approved all animal protocols.

Histology and immunohistochemistry
These techniques were performed on paraformaldehyde-fixed, paraffin
imbedded slides as previously described (High et al., 2008). Mutant and
littermate control embryos were generated from Wnt1-Cre; Hdac3f/+; Z/EG, Wnt1Cre; Hdac3f/+ or Pax3Cre/+; Hdac3f/+ animals crossed to Hdac3f/+, Hdac3f/+; Z/EG
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or Hdac3f/f animals, respectively. Embryos were dissected in cold PBS, fixed
overnight in 2% paraformaldehyde, dehydrated into 100% ethanol, embedded in
paraffin and sectioned. H&E and Goldnerʼs trichrome staining were performed
using standard procedures. Primary antibodies used for immunohistochemistry
were anti-GFP goat polyclonal (Abcam AB6673, 1:100), anti-GFP rabbit
polyclonal (Invitrogen A-11122, 1:200) and rabbit polyclonal anti-Hdac3 (Santa
Cruz sc-11417x, 1:10).
All control versus mutant histological and immunohistochemical images
were taken at the same exposure and contrast settings, using NIS Elements
software. ImageJ software was used to merge images and for quantification of
neurofilament and tyrosine hydroxylase staining intensity. In some cases, ImageJ
was used to decrease image brightness, and this was performed identically in
control and mutant images.
Cell number, proliferation and apoptosis were quantified by manually
counting nuclei, pHistone H3-, or Tunel-positive cells, respectively, in adjacent
sections of the anatomically-defined palatal shelf region in a blinded manner.

Optical projection tomography
E10.5 embryos were fixed in 4% paraformaldehyde overnight. Embryos
were bleached for 30 minutes in 5% H2O2 in PBST, digested in 10µg/mL
proteinase K in PBST for 5 minutes and immunostained with mouse polyclonal
Anti-2H3 (Iowa Hybridoma Bank, 1:100). An HRP Conjugated secondary
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antibody and DAB substrate kit (Vector Laboratories) were used to visualize
peripheral nerves.
For OPT scanning, embryos were dehydrated into 100% methanol,
embedded in 1% low-melt agarose, cleared overnight in 1:2 (v/v) benzyl alcohol
and benzyl benzoate, and scanned using the Bioptonics OPT scanner (3001M)
(Sharpe et al., 2002). Image stacks were reconstructed using OsiriX software.
Image contrast was optimized to reveal peripheral nerve patterning.

Alcian blue/alizarin red staining
Embryos and neonatal mice were fixed for 7 days in 90% ethanol for one
week at 4°C. Samples were stained for 3-5 days at room temperature with Alcian
blue solution (0.2mg/ml Alcian Blue, 80% ethanol, 3.5M acetic acid) to visualize
cartilage, and then rehydrated with an ethanol/water gradient. Samples were then
incubated with 1% KOH for 2, followed by incubation for 3 days with Alizarin Red
solution (0.05mg/ml Alizarin Red S in 1% KOH) to visualize bone, followed by 3
washes (2-3 hours each) in 1% KOH solution.

Anterior cranial mesenchyme explant cultures
The anterior cranial mesenchyme of wild type CD1 embryos was
dissected in sterile PBS supplemented with 1% penicillin/streptomycin (Gibco).
Tissue was triturated in cold 0.25% trypsin (Gibco), incubated on ice for 5
minutes, and then at 37°C for 10 mins on a nutator. 10% v/v FBS was used to
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stop trypsination, cells were further triturated to a single cell suspension, spun at
300x g for 5 minutes, resuspended in αMEM (Invitrogen A10490-01), filtered
through a 40μm filter, and played in 6-well plates. After two hours, cells were
transfected with 5nmol of total siRNA using 4 μL of Lipofectamine 2000
(Invitrogen) per well in 600μL total volume of serum free αMEM and Optimem
(Gibco). Control siRNA (D-001810), Hdac3 siRNA (L-043553), and Bmp4 siRNA
(L-043095) were obtained from Thermo Scientific. After overnight transfection,
media was replaced with serum-free αMEM and cells were grown for an
additional 24 hours before being harvested for RNA isolation.

RNA isolation, complementary DNA synthesis and quantitative RT-PCR
From explanted cranial mesenchyme, RNA was harvested in 1mL of Trizol
(Invitrogen). Cells were sheared with trituration and by being passed twice
through a 26 gauge needle.
For E12.5 cranial mesenchyme expression profiling, Wnt1-Cre; Hdac3f/f
and litermate Cre-negative control embryos were microdissected with tungsten
needles in cold PBS. Samples were immediately immersed in 1mL Trizol and
homogenized with a handheld homogenizer. Samples were passed twice through
a 26 gauge needle to shear genomic DNA and incubated at room temperature for
10 minutes. 100μL of BCP reagent (Molecular Research Center) was added to
samples, which were mixed for 15s and spun in a microcentrifuge at 11.5k rmp
for 15mins at 4°C. The aqueous phase was then combined with 600μL of 70%
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ethanol. The sample was applied to a Qiagen RNeasy spin column, and
subsequent kit steps, including on column DNAse I digestion, were followed.
Total RNA was eluted in 50μL of RNAse free water (Qiagen), and evaporated
down to a total volume of 15μL. Complementary DNA (cDNA) was synthesized
according to kit instructions with the Superscript III system (Invitrogen).
Quantitative RT-PCR was performed in triplicate using Sybr Green
(Applied Biosystems). Gapdh was used as a reference control gene. Primer
sequences (Table 2.3) were designed using IDT software, unless otherwise
indicated. All primer pairs were designed to flank exon-exon junctions. Primer
pairs were validated with a four point standard curve, and only primers offering r2
values >0.97 were used.

Statistics
The chi-squared test and studentʼs two-tailed t test were used to ascertain
differences between groups. A x2 or p-value of less than 0.05 was considered
significant.
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Table 2.1. Hdac3Wnt1NCKO mice exhibit perinatal lethality.

Wnt1-Cre; Hdac3f/+ x Hdac3f/+
E16.5-E18.5
# Observed
+/+
Hdac3
9
Hdac3f/+
17
Hdac3f//f
8
+/+
Wnt1-Cre; Hdac3
7
f/+
Wnt1-Cre; Hdac3
23
Wnt1-Cre; Hdac3f/f
11
Total
75
Chi Sq
0.82
P1
Hdac3+/+
Hdac3f/+
Hdac3f//f
Wnt1-Cre; Hdac3+/+
f/+

Wnt1-Cre; Hdac3
Wnt1-Cre; Hdac3f/f
Total
Chi Sq

Observed
0.12
0.23
0.11
0.09
0.31
0.15

#Expected
9
19
9
9
19
9

Expected
0.13
0.25
0.13
0.13
0.25
0.13

# Observed
10
26
10

Observed
0.14
0.36
0.14

# Expected
9
18
9

Expected
0.13
0.25
0.13

9

0.12

9

0.13

18
0
73
0.03

0.25
0

18
9

0.25
0.13
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Table 2.2. Late gestation and perinatal craniofacial abnormalities in
Hdac3Wnt1NCKO mice.

E16.5-P0

Wnt1-Cre

Wnt1-Cre; Hdac3f/f

Microcephaly

0% (0/14)

100% (19/19)

Cleft palate

0% (0/14)

100% (19/19)

Eyelid closure defects

0% (0/14)

100% (19/19)

Calvarium

0% (0/5)

100% (3/3)

Mandible

0% (0/5)

100% (3/3)

Base of skull

0% (0/5)

100% (3/3)

Tympanic rings

0% (0/5)

33% (1/3)

Ossification defects of:
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Table 2.3. Quantitative RT-PCR primer sequences
Gene name

Protein

Alpl

Alkaline
phosphatase

Bmp2

Sequence (5ʼ – 3ʼ)

Product size

Genomic size

TGCAAGGACATCGCATATCAG
TCCAGTTCGTATTCCACATCAG

116

2975

Bmp2

CGCAGCTTCCATCACGAA
TGCAGATGTGAGAAACTCGTC

117

6222

Bmp4

Bmp4

GAGCAGAGCCAGGGAAC
GAAGAGGAAACGAAAAGCAGAG

138

1140

Ccnd1

Cyclin D1

GCCCTCCGTATCTTACTTCAAG
GCGGTCCAGGTAGTTCATG

145

1538

Ccnd3

Cyclin D3

GCGTGCAAAAGGAGATCAAG
GATCCAGGTAGTTCATAGCCAG

120

1001

Ccng1

Cyclin G1

CAGTTCTTTGGCTTTGACACG
TTCCTCTTCAGTCGCTTTCAC

147

1597

Cdk2

Cdk2

GCATTCCTCTTCCCCTCATC
GGACCCCTCTGCATTGATAAG

128

1251

Cdk4

Cdk4

TACATACGCAACACCCGTGGACAT
AGTCGTCTTCTGGAGGCAATCCAA

155

931

Cdkn1a

p21

CTTGCACTCTGGTGTCTGAG
GCACTTCAGGGTTTTCTCTTG

145

651

Cdkn1b

p27

TGGACCAAATGCCTGACTC
GGGAACCGTCTGAAACATTTTC

144

705

Cdkn1c

p57

CAGGACGAGAATCAAGAGCAG
CGACGCCTTGTTCTCCTG

150

694

Cdkn2a

p16 Ink4a
(Trivedi et al.,
2008)

ATCTGGAGCAGCATGGAGTC

198

5198

Cdkn2c

p18

AAACGTCAACGCTCAAAATGG
GACAGCAAAACCAGTTCCATC

133

3524

Cdkn2d

p19 Ink4d

CTTCATCGGGAGCTGGTG
AGGCATCTTGGACATTGGG

138

1140

Dmp1

Dmp1

CCCAGTTGCCAGATACCAC

140

4503

CGAATCTGCACCGTAGTTGA
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CACTATTTGCCTGTCCCTCTG
Gapdh

Gapdh

CGTCCCGTAGACAAAATGGT
GAATTTGCCGTGAGTGGAGT

177

2011

Hdac1

Hdac1

GAGATGACCAAGTACCACAGTG
AAACAAGCCATCAAACACCG

135

4741

Hdac2

Hdac2

AGAAGGAGACAGAGGACAAGA
CGAGGTTCCTAAAGTTGGAGAG

144

3045

Hdac3

Hdac3

CCATTCTGAGGACTACATCGAC
TGTGTAACGGGAGCAGAAC

142

6837

Hdac8

Hdac8

ACCGAATCCAGCAAATCCTC
CAGTCACAAATTCCACAAACCG

149

22619

Msx1

Msx1

AAGATGCTCTGGTGAAGGC
TGGTCTTGTGCTTGCGTAG

132

2296

Msx2

Msx2

CTCGGTCAAGTCGGAAAATTC
GTTGGTCTTGTGTTTCCTCAG

121

3859

Msx3

Msx3

AGTCGCGCACTCTTGTC
TATTGCTTCTGGTGAAACTTGC

141

786

Nog

Noggin

ATCTGGAGCAGCATGGAGTC
CGAATCTGCACCGTAGTTGA

116

116

Opg

Osteoprogerin

AAGAGCAAACCTTCCAGCTGC
CACGCTGCTTTCACAGAGGTC

104

1762

Osr1

(Hesse et al.,
2010)
Osr1

GATGAGCGACCTTACACCTG
ATCCTTTCCCACACTCTTGAC

124

820

Osr2

Osr2

TTGCTCATTCACGAGAGGAC
TCCCACACTCCTGACATTTG

145

1101

Osx

Osterix

345

None

Rankl

(Hesse et al.,
2010)
RANK ligand

114

5355

Runx2

Runx2

91

58590

TCTGCTTGAGGAAGAAGCTCACTAT
GGC
AGGCAGTCAGACGAGCTGTGC

AGGCTCATGGTTGGATGTG
GAGGACAGAGTGACTTTATGGG
GCTATTAAAGTGACAGTGGACGG
GGCGATCAGAGAACAAACTAGG
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Scx

Scleraxis

ACACCCAGCCCAAACAG
TCCTTCTAACTTCGAATCGCC

97

992

Shh

Sonic
hedgehog

TCCAAAGCTCACATCCACTG
CGTAAGTCCTTCACCAGCTTG

128

2846

Smo

Smoothened

AGCTGCCACTTCTATGACTTC
GATCTCACAGTCAGGAATGGG

126

1096

Spry2

Sprouty 2

AGAGGATTCAAGGGAGAGGG
ATCAGGTCTTGGCAGTGTG

96

2882

Tbx1

Tbx1

TGGGACGAGTTCAATCAGC
TGTCATCTACGGGCACAAAG

145

1544

Tbx2

Tbx2

CACAAACTGAAGCTGACCAAC
GAAGACATAGGTGCGGAAGG

147

1054

Tbx3

Tbx3

AGCCAACGATATCCTGAAACTG
GTGTCTCGAAAACCCTTTGC

150

1946

Trp53

p53

AGTTCATTGGGACCATCCTG
GCTGATATCCGACTGTGACTC

149

6524

Zfp521

Zfp521

ACAAGATCCATCAGTGCCAG
CTCTCCGAAATCACACCCTTC

134

9196
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Figure 2.1
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Figure 2.1. Deletion of Hdac3 in neural crest results in cranial hypoplasia at
E10.5. A. Immunohistochemistry for GFP and Hdac3 in frontal sections of the
dorsal neural tube (DNT) and dorsal root ganglia (DRG) at E10.5. Wnt1-Cre
derivatives marked by GFP expression are found in the control (left) and mutant
DNT and DRG. Mutants exhibit efficient deletion of Hdac3 in premigratory neural
crest cells in the DNT (arrowhead) and in postmigratory cells in the DRG (arrow),
while control embryos show Hdac3 expression in both regions. B. Gross
fluorescent images of E9.5 embryos. Neural crest cells populate the developing
face

and

pharyngeal

arches

in

control

and

mutant

embryos.

C.

Immunohistochemistry for GFP and Hdac3 in frontal sections of the rostral
pharyngeal arches in E10.5 embryos. While the first pharyngeal arch (open
bracket) is populated by Wnt1-Cre derivates in both control and mutant embryos,
Hdac3 is efficiently deleted, specifically in neural crest-derived cells (arrowhead).
D. Quantification of first pharyngeal arch size in three serial sections from control
and mutant embryos. Error bars indicate standard error of the mean. Asterisk
denotes p < 0.05. Scale bars: A: 100μm. B: 300μm. C. 400μm.
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Figure 2.2
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Figure 2.2. Craniofacial abnormalities in Hdac3Wnt1NCKO mice. A. Gross image
of a control (left) and mutant P0 pup. Mutants have severe cranial hypoplasia,
characterized by a shortened snout (bracket) and micrognathia, and are unable
to feed, as indicated by the lack of a milk spot (arrowhead). Mutants also exhibit
eyelid dysplasia (arrow). B. Optical projection tomography renderings of P0
heads. (Left panels) Viewed en face, an area of hemorrhage (black arrowhead)
and eyelid closure defects (white arrowhead) are visible in the mutant. (Right
panels) Virtual transverse sections cut through the level of the eyes
demonstrates a cleft palate (arrow) in the mutant. C. H&E stained coronal
sections of E17.5 heads. Cleft palate is indicated by the arrow. S: Nasal septum.
T: Tongue. Scale bars: A: 500μm. B: 2mm. C: 1.4mm.
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Figure 2.3
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Figure 2.3. Deletion of Hdac3 with Pax3Cre recapitulates the craniofacial
abnormalities observed using Wnt1-Cre. Gross images of E15.5 embryos.
The mutant exhibits pronounced microcephaly and shortened snout. Scale bar:
800μm.
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Figure 2.4
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Figure 2.4. Hdac3Wnt1NCKO embryos exhibit defects in craniofacial bone due
to dysregulation of important regulators of ossification. A. Alcian blue and
alizarin red staining of E17.5 heads. Purple staining indicates ossified bone, blue
staining indicates cartilage. Mutants exhibit incomplete ossification of the
sphenoid bone (white arrowhead), complete absence of ossification of the frontal
bone (F) (black arrowhead), and decreased ossification of viscerocranial
structures such as the tympanic ring (T) (arrow). M: Mandible. B. Goldnerʼs
trichrome staining of E17.5 heads. Green staining represents bone, red staining
represents connective tissues. (Inset i) Asterisk (*) indicates cleft palate in the
mutant. (Inset ii) Open bracket indicates an area of brain herniating through the
base of the skull in the mutant. (Inset iii): Decreased ossification of the calvarium
(C) in the mutant. C. Quantitative RT-PCR analysis for regulators of ossification,
performed on E14.5 microdessected anterior cranial mesenchyme. Gross
fluorescent images on the left show representations of the area that was
microdissected to obtain RNA. D. Representative mmunohistochemistry for
Runx2 and GFP in frontal sections of E14.5 heads. Neural-crest derived cells,
marked by GFP expression, show decreased expression of Runx2 in regions
corresponding to the base of the skull and calvarium.
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Figure 2.5
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Figure 2.5. The loss of Hdac3 causes hypoplasia of neural crest-derived
dental mesenchyme. A-F. H & E stained frontal sections of control and mutant
heads at E17.5. Early stages of tooth morphogenesis, including epithelial
invagination (A & B), and mesenchymal specification (C & D) occur normally in
the absence of Hdac3. E&F. However, at E17.5, the dental pulp shows
decreased bulk in mutants. Ep: Epithelium. M: mesenchyme. Scale bar 200μm.
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Figure 2.6
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Figure 2.6. Cell cycle dysregulation and increased apoptosis underlie cleft
palate in Hdac3Wnt1NCKO mice. A-H. H&E stained frontal sections of control and
mutant embryos at the level of the palatal shelves. A-D. In control embryos, the
palatal shelves (P) expand towards the mandible (M) before elevating above the
tongue (T), meeting in the midline at E14.5 and ossifying by E17.5. E-H. In
mutant embryos, the palatal shelves are severely hypoplastic at E12.5 and do not
meet in the midline at E14.5 (*), although the medial aspects of the palatal
shelves do elevate above the tongue (arrowheads). I. Images on the left show
the areas defined as palatal shelves in control and mutant embryos at E12.5.
Phospho-histone H3 (pH3)- (arrows) and Tunel- (arrowheads) positive nuclei
were counted relative to total nuclei in serial sections of the pharyngeal arch
mesenchyme. C. Representative gross fluorescent images showing the area of
cranial mesenchyme microdissected for expression profiling. D&E. Quantitative
RT-PCR results for class I Hdacs (D) and cell cycle regulators (E) in E12.5
cranial

mesenchyme.

Scale

bars:

A:
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400μm.

B:

50μm.

C:

150μm.

Figure 2.7
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Figure 2.7. Loss of p21 does not rescue craniofacial abnormalities in
Hdac3Wnt1NCKO mutants. H&E stained frontal sections of E16.5 heads. Neural
crest deletion of Hdac3 on a p21+/- or p21-/- background results in cleft palate
(arrow). Scale bar: 400μm.

	
  
66	
  

Figure 2.8
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Figure

2.8.

Bmp4

and

downstream

targets

are

dysregulated

in

Hdac3Wnt1NCKO cranial mesenchyme. A-B. Quantitative RT-PCR from E12.5
cranial mesenchyme for (A) transcription factors known to regulate the cell cycle
in cranial neural crest and palatogenesis and (B) Important signaling molecules
involved in these processes. C. Quantitative RT-PCR from explanted cranial
crest cells treated with control, Hdac3 or Bmp4 siRNA. The critical downstream
Bmp4 target Msx2 is upregulated in the absence of Hdac3, and dysregulation is
rescued by Bmp4 knockdown. Numbers above brackets denote p values in
studentʼs two-sided t test.
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Chapter

3.

Hdac3

regulates

smooth

muscle

differentiation in neural crest cells and development of
the cardiac outflow tract

This chapter contains data and text that has been published in Circulation
Research (Singh et al., 2011).

Summary
Chapter 2 discusses craniofacial abnormalities resulting from neural crest
deletion of Hdac3. Neural crest cells in more caudal regions of the embryo make
important contributions to the smooth muscle of the cardiac outflow tract (OFT)
and great vessels, the neurons and support cells of the peripheral nervous
system, and the chromaffin cells of the adrenal medulla. In this chapter, I
describe the role of Hdac3 in cardiac OFT development, and contrast it to the
role of Hdac3 in neural crest-mediated craniofacial and nervous system
development.
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Introduction
Like craniofacial development, mammalian cardiac outflow tract and aortic
arch morphogenesis is characterized by the tightly coupled development of
multiple cell types. The complexity of this process is underscored by the
prevalence of congenital anomalies of great vessel patterning in humans (Jain et
al., 2010). As discussed in Chapter 1, the heart, OFT and aortic arch are formed
by several developmentally distinct cell populations, including cardiomyocytes
(derived from the first and second heart fields), vascular smooth muscle cells
(derived from the second heart field and neural crest), and endothelial cells
(Vincent and Buckingham, 2010). These populations of cells interact within the
maturing pharyngeal arches - a dynamic milieu in which cross-regulation
between these cell types, as well as the pharyngeal endoderm and ectoderm,
results in the coordinated development of the OFT, great vessels and
neighboring structures (Park et al., 2008, Guo et al., 2011). Many of the
processes that regulate cell fate decisions and patterning during OFT
development are also active in vascular remodeling in adult disease states in
humans (Yoshida and Owens, 2005).
The OFT initially develops as a single vessel, the truncus arteriosus,
comprised of myocardium and smooth muscle cells emerging from a single,
unseptated ventricle. Neural crest cells, which make up the bulk of the
pharyngeal arch mesenchyme, contribute to the smooth muscle of the OFT and
also condense to form much of the smooth muscle of the aortic arch arteries - a
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series of paired vessels that connect the developing truncus arteriosus to the
dorsal aortae (Stoller and Epstein, 2005). The aortic arch arteries are then
extensively remodeled, eventually giving rise to the mature aortic arch and
several great vessels. Neural crest cells also contribute to septation and rotation
of the OFT, with secondary effects on septation of the ventricles. These
processes are highly dependent on the migration, expansion and differentiation
of cardiac neural crest in response to cues from neighboring cells (Jain et al.,
2010).
Murine models of congenital cardiovascular abnormalities have shed new
light on the interplay between cell populations in the pharyngeal arches, as well
as on the pathogenesis of human congenital cardiac disease. For instance,
human mutations in components of the Notch signaling pathway can result in
Alagille syndrome, a heterogeneous disorder that can include cardiac OFT
defects. It has been demonstrated in mice that active Notch signaling in both
neural crest cells and the second heart field is critical for OFT morphogenesis
(High et al., 2007, High et al., 2009). Notch signaling from endothelial cells to
neural crest in the pharyngeal mesenchyme via the Notch ligand Jagged1 is
required to initiate smooth muscle differentiation in the aortic arch arteries; in the
absence of such signaling, mice develop cardiac abnormalities reminiscent of
those found in Alagille patients (High et al., 2007).
Normal development of the OFT relies on intact migration of neural crest
cells into the pharyngeal arches, survival and proliferation of post-migratory
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neural crest, differentiation of neural crest cells into smooth muscle, and rotation
of the developing vasculature, which creates the stereotyped, three-dimensional
structure of the mature OFT. While Notch signaling drives smooth muscle
differentiation, other signaling modalities including the WNT, FGF and TGFß
pathways, as well as activation of the MAPK pathway by integrin signaling
mediate these additional stages of OFT formation and remodeling (Huh and
Ornitz, 2010, Guo et al., 2011, Zhang et al., 2010b, Newbern et al., 2008, VallejoIllarramendi et al., 2009).
In addition to numerous signaling pathways, epigenetic processes and
chromatin remodeling agents have also been shown to regulate aspects of OFT
development (Chang and Bruneau, 2011). Human mutations in the chromatin
remodeling enzyme Chd7 have been associated with neurocristopathy and OFT
abnormalities (Lalani et al., 2006). In the mouse, Chd7 expression in pharyngeal
ectoderm regulates the growth of the fourth and sixth pharyngeal arteries and
formation of the aortic arch (Randall et al., 2009). Chd7 is also required cellautonomously by human embryonic stem cell-derived neural crest cells, in order
to regulate neural crest specification and migration (Bajpai et al., 2010). Chd7
directly interacts with the PBAF (polybromo- and Brg1-associated factorcontaining complex) chromatin remodeling complex in order to regulate the
expression of Sox9 and Twist1, both of which play crucial roles in neural crest
(Bajpai et al., 2010). Brg1-containing nucleosome remodeling complexes also
regulate the expression of smooth muscle contractile proteins, and smooth
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muscle-specific deletion of the Brg1 gene in mice results in partially penetrant
patent ductus arteriosus (Zhang et al., 2011). In the second heart field, Brg1
expression is required to mediate proliferation and OFT patency (Hang et al.,
2010).
Histone methylation is an important epigenetic maintainer in many
developmental processes, including in OFT formation. The polycomb repressor
complex protein Rae28 regulates cardiac expression of the transcription factor
Nkx2.5, and Rae28-/- mutant mice demonstrate abnormalities such as double
outlet right ventricle (DORV) (Shirai et al., 2002). Similarly, endothelial deletion of
the histone demethylase Jarid2 results in cardiac abnormalities and OFT
abnormalities including DORV. Loss of Jarid2 results in upregulation of Notch1,
which drives smooth muscle differentiation in neural crest cells; this provides an
example of epigenetic control of an important signaling pathway in OFT formation
(Mysliwiec et al., 2011).
As discussed in Chapter 1, it is unsurprising that a process as intricate as
OFT development requires tight regulation of transcription factors and signaling
molecules by many chromatin remodeling complexes. However, while many such
complexes have been implicated in OFT development, Class I Hdacs have not
previously been shown to modulate any aspects of this process. In fact, genetic
deletion of either Hdac1, Hdac2 or Hdac8 in neural crest does not affect OFT
development (Haberland et al., 2009a). In this chapter, I use in vivo and ex vivo
approaches to determine the role of Hdac3 in cardiac outflow tract development
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and show that there is a specific requirement for Hdac3 in cardiac neural crest
cells undergoing smooth muscle differentiation. Furthermore, I show evidence of
a genetic interaction between Hdac3 and the Notch signaling pathway in
regulating this process.
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Results

Hdac3 is efficiently deleted in cardiac and trunk neural crest derivatives by
Wnt1-Cre
Immunohistochemical analysis reveals that Hdac3 is normally expressed
in the neural crest-derived pharyngeal arch mesenchyme (Figure 3.1 A),
conotruncal cushions of the developing outflow tract (Figure 3.1B) and chromaffin
cells of the adrenal medulla (Figure 3.1 C) embryos at E10.5. In Hdac3Wnt1NCKO
mutant embryos, Hdac3 protein is absent in each region (Figure 3.1 A-C). Costaining for GFP in embryos expressing the Z/EG reporter confirms that Hdac3
deletion is specific to neural crest derivatives.
Quantification of the total number of GFP-positive cells populating the
caudal pharyngeal arches reveals no significant difference between control and
mutant embryos at E11.5 (Figure 3.1 D. Therefore the specification and migration
of cardiac neural crest cells remains intact despite efficient deletion of Hdac3.
This lies in contrast to the situation in the rostral pharyngeal arches, in which loss
of Hdac3 leads to pronounced hypoplasia at E10.5 (discussed in Chapter 2).

Loss of Hdac3 in neural crest results in severe cardiovascular and thymus
abnormalities
In neurocristopathy in humans, and in multiple mouse models in which
neural crest developmental processes have been disrupted, craniofacial
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abnormalities often also portend cardiovascular abnormalities. As neural crest
cells make important contributions to the development of the cardiac OFT, we
sought to analyze OFT morphology in Hdac3Wnt1NCKO embryos. Neural crest gives
rise to the smooth muscle of the aortic arch from its origin to the ductus
arteriosus and large proportions of the smooth muscle in the great arteries. This
smooth muscle is critical for vascular integrity during development. In several
mutant embryos, we observed complete absence of the preductal aortic arch
(Figure 3.2 A versus 3.2 B), a condition known as interrupted aortic arch (IAA)
type B in humans. Other mutants demonstrated aortic arch hypoplasia (Figure
3.2 C). Both IAA type B and aortic arch hypoplasia are rare cardiac abnormalities
in humans, although both are commonly found in patients with DiGeorge
syndrome and other neurocristopathies (Morini et al., 2001).
In addition to contributing directly to the aortic arch and great arteries,
neural crest cells are involved in septation and rotation of the OFT, and directly
give rise to the smooth muscle of the aorticopulmonary septum.

Failure of

septation can result in persistent truncus arteriosus (PTA), while a combination of
incomplete septation and deficient outflow tract rotation can result in DORV. We
observed examples of PTA and DORV in Hdac3Wnt1NCKO embryos (Figure 3.2 D
and data not shown). It is thought that neural crest cells in the developing
aorticopulmonary septum signal to adjacent myocardium during the formation of
the intraventricular septum. Consistent with the role of neural crest-derived
smooth muscle in ventricular septation, we have observed severe ventricular
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septal defects (VSDs) in many Hdac3Wnt1NCKO embryos (Figure 3.2 E). Table 3.1
summarizes the cardiovascular abnormalities observed in late gestation
Hdac3Wnt1NCKO embryos.
In order to provide further support for our findings, we used a distinct
neural crest Cre driver, Pax3Cre, to delete Hdac3. Hdac3Pax3NCKO also die by P1
and exhibit a similar array of cardiovascular defects as Hdac3Wnt1NCKO embryos
(Figure 3.3, Table 3.2, Table 3.3). These findings support the conclusion that
Hdac3 is required in cardiac neural crest.
The thymus is derived primarily from endoderm but develops in close
association with the pharyngeal arches and neural crest. The thymic primordia
migrate caudally through the pharyngeal mesenchyme during midgestation to
final destinations in the anterior mediastinum. The thymuses of Hdac3Wnt1NCKO
embryos fail to descend appropriately and are dysplastic (Figure 3.4).

The

abnormal thymic development in Hdac3Wnt1NCKO embryos is consistent with prior
studies that have documented the vital role of neural crest during thymus
development, including in thymic migration, intrathymic smooth muscle formation,
pericyte formation, and egress of thymocytes (Foster et al., 2008, Foster et al.,
2010, Zachariah and Cyster, 2010).

Peripheral neurogenesis and development of the adrenal medulla occur
normally in Hdac3Wnt1NCKO embryos
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In addition to smooth muscle of the OFT, neural crest cells in the cardiac
and trunk region form the neurons that populate the dorsal root, sympathetic and
enteric ganglia, and the chromaffin cells of the adrenal medulla. In order to
determine the requirements for Hdac3 in the formation of these derivatives, we
first analyzed the peripheral nervous system of Hdac3Wnt1NCKO embryos. The
neurofilament 2H3 is a marker of differentiated neurons. Immunostaining for 2H3
and GFP reveals that differentiated neurons populate the dorsal root ganglia and
enteric ganglia of E10.5 Hdac3Wnt1NCKO; Z/EG embryos, and that these cells are
neural crest-derived (Figure 3.5 A and data not shown). Quantification of
peripheral neuron staining intensity in the dorsal root ganglia reveals no
significant difference between mutant and control embryos (Figure 3.5B). Optical
projection tomography reconstructions of whole mount 2H3-stained embryos
revealed normal patterning of the peripheral nervous system, including cranial
nerves, dorsal root and sympathetic ganglia, in Hdac3Wnt1NCKO embryos
compared to controls (Figure 3.5 C).
The adrenal medullae of E14.5 Hdac3Wnt1NCKO; Z/EG embryos also
develop normally when compared to control littermates, as determined by
immunohistochemistry for the neuroendocrine marker tyrosine hydroxylase (TH)
and for GFP (Figure 3.6). Quantification of TH staining intensity reveals no
significant abnormalities in chromaffin cell development in the absence of Hdac3
(Figure 3.6).
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The aortic arch arteries of E11.5 Hdac3Wnt1NCKO embryos show decreased
expression of smooth muscle markers
In midgestation, neural crest cells make up the bulk of the mesenchyme in
the third, fourth, and sixth pharyngeal arches (Figure 3.1 A,D, Figure 3.7 A,B). A
subset of these cells directly apposes the endothelium of the developing aortic
arch arteries (Figure 3.7 B). Between E10.5 and E11.5, these neural crest
derivatives condense in response to signals from the endothelium and
differentiate into the smooth muscle of the aortic arch arteries, eventually giving
rise to a layer of smooth muscle actin (SMA)-positive tissue that is normally
several cells thick by E11.5 (Figure 3.7 A, C, D) (High et al., 2008). In mutant
embryos, as in littermate controls, neural crest cells appropriately populate the
mesenchyme surrounding the arch arteries (Figure 3.1 D, 3.4 E, F). However, in
three of four E11.5 mutant embryos, we observed profound deficiencies in
smooth muscle populating the nascent arch arteries, as assessed by
immunohistochemistry for SMA and the additional smooth muscle marker SM22α
(Figure 3.7 E, G, H, Figure 3.8). These defects are particularly pronounced in the
left fourth and sixth arteries (Figure 3.7 E, I), which give rise to the preductal
aortic arch and ductus arteriosus, respectively – areas that are affected in late
gestation Hdac3Wnt1NCKO mutants (Table 3.1). Of note, parts of the second arch
arteries that are largely populated by non-neural crest-derived smooth muscle
cells develop normally in mutants (Figure 3.7 A, E, I). The 75% penetrance of
gross smooth muscle deficiencies in the caudal arch arteries at E11.5 parallels
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the penetrance of aortic arch abnormalities observed at E17.5 in Hdac3Wnt1NCKO
embryos (Table 3.1). Mid-gestational decreases in aortic arch artery smooth
muscle have previously been shown to portend OFT defects (High et al., 2007),
and we therefore hypothesized that these smooth muscle deficiencies observed
at E11.5 account for the late gestational cardiovascular phenotype observed in
Hdac3Wnt1NCKO embryos.

Hdac3-deficient neural crest cells exhibit a cell autonomous defect in
smooth muscle differentiation
In order to determine the mechanism underlying smooth muscle
abnormalities in E11.5 Hdac3Wnt1NCKO embryos, we first determined rates of
proliferation and apoptosis in third, fourth and sixth pharyngeal arch
mesenchyme at E11.5 using phospho-histone H3 and Tunel staining,
respectively. In contrast to the abnormal cell cycle regulation observed in the first
pharyngeal arch (Chapter 1), neither proliferation nor apoptosis rates are
significantly altered in the caudal Hdac3Wnt1NCKO arches when compared to
littermate controls (Figure 3.7 J). This suggests that neither increases in cell
death in arch artery smooth muscle, nor decreased smooth muscle proliferation
contribute to the defects observed.
Based upon our in vivo observations, we hypothesized that neural crest
expression of Hdac3 is required for smooth muscle differentiation. We used an
ex vivo approach to test this hypothesis. We performed neural tube explant
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assays using E9.5 Hdac3Wnt1NCKO; Z/EG and Wnt1-Cre; Z/EG control embryos.
Genetically labeled neural crest cells were allowed to migrate from the dorsal
neural tube onto a surrounding layer of fibronectin under conditions that allow for
spontaneous differentiation into smooth muscle. Both control and Hdac3-deficient
neural crest cells are able to migrate from the dorsal neural tube onto the
fibronectin layer (Figure 3.9 A, B). However, while control cells assume a large,
flat conformation after two days in culture, mutant cells maintain a rounder
phenotype (Figure 3.9 A, B). Co-staining for GFP and SMA revealed that control
cells are able to efficiently form smooth muscle in culture, while the proportion of
GFP-positive cells costaining for SMA is significantly lower in mutant explant
cultures (Figure 3.9 C-G). These results suggest that Hdac3-deficient neural
crest cells exhibit a primary defect in smooth muscle differentiation, consistent
with the decreased smooth muscle observed in E11.5 mutant aortic arch arteries.

The Notch ligand Jagged1 is downregulated in Hdac3Wnt1NCKO aortic arch
arteries
Notch signaling via the Jagged1 ligand is critical for smooth muscle
formation in neural crest cells, and loss of Notch signaling in the neural crest
results in a similar array of OFT defects as observed in this study, with similar
decreases in aortic arch artery smooth muscle at E11.5 (High et al., 2007).
Jagged1 is initially expressed in the endothelial cells of the nascent aortic arch
arteries at E10.5, and in a positive feedback loop, Jagged1 expression is
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upregulated in surrounding neural crest cells in response to Jagged1-mediated
Notch activation (High et al., 2008, Feng et al., 2010). OFT development is
exquisitely dependent on endothelial and neural crest expression of Jagged1;
indeed, even heterozygous deletion of Jagged1 in neural crest portends OFT
defects (L. Manderfield, 2011 Circulation, accepted for publication).
Immunohistochemistry in Hdac3Wnt1NCKO embryos demonstrates that
Jagged1 expression in the aortic arch arteries is significantly decreased at E11.5
when compared to Wnt1-Cre littermate controls (Figure 3.10A). Quantification of
Jagged1 staining intensity in the region surrounding each aortic arch artery
indicates that deficient Jagged1 expression is most prominent in the
mesenchyme surrounding the left fourth aortic arch artery (Figure 3.10B). This
finding is consistent with our observations of decreased smooth muscle formation
in this artery, and abnormal development of the left fourth arch artery derivatives
in late gestation.
In order to determine the importance of Notch signaling in mediating the
cardiovascular phenotype of Hdac3Wnt1NCKO embryos, we crossed a conditional,
constitutively active form of the Notch effector molecule, NICD, into the
Hdac3Wnt1NCKO background (Stanger et al., 2005). We found that Wnt1-Cre;
R26NICD/+ embryos die between E12.5-E14.5 of neural tube closure defects (data
not shown). These embryos also demonstrate gross abnormalities in the
morphology of the pharyngeal arches, with complete ablation of the left fourth
and sixth arches at E11.5 (data not shown). These abnormalities preclude direct
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comparison of the morphology at these regions between control and
Hdac3Wnt1NCKO embryos in the presence versus the absence of NICD expression.
However, the area of confluence of the right fourth and sixth arteries remains in
embryos overexpressing NICD in neural crest. Therefore we have evaluated both
Jagged1 and SMA staining in this region of the arch arteries.
Wnt1-Cre; R26NICD/+ embryos demonstrate increased SMA staining as well
as increased expression of Jagged1 compared to Wnt1-Cre embryos (Figure
3.11A-F). These observations are consistent with the role of Notch signaling in
promoting both cell autonomous smooth muscle differentiation as well as
Jagged1 expression in surrounding cells. In the setting of Hdac3 conditional
mutants, we have observed increased SMA staining in Wnt1-Cre; Hdac3f/f;
R26NICD/+ embryos compared to Wnt1-Cre; Hdac3f/f litermates; this SMA staining
is comparable to that observed in Wnt1-Cre; R26NICD/+ embryos (Figure 3.11G-L.
However, we do not observe ectopic Jagged1 expression in Wnt1-Cre; Hdac3f/f;
R26NICD/+ embryos, as in Wnt1-Cre; R26NICD/+ arches (Figure 3.11G-L).
Constitutive Notch activation in neural crest therefore results in cell
autonomous rescue of smooth muscle expression, without ectopic expression of
Jagged1. These observations are consistent with a model in which Hdac3 is
important in mediating Notch-mediated Jagged1 expression.
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Discussion

In this study, we have elucidated a specific role for Hdac3 in smooth
muscle differentiation of cardiac neural crest cells during OFT and aortic arch
artery morphogenesis. The specificity of this role is underscored by the lack of
peripheral nervous system or adrenal abnormalities in Hdac3Wnt1NCKO mutants.
The smooth muscle deficiencies observed in Hdac3Wnt1NCKO embryos lead to OFT
and aortic arch artery abnormalities, such as DORV, PTA and type B IAA –
abnormalities that are attributable to a failure of cardiac neural crest-derived
structures to form properly (Stoller and Epstein, 2005). It is interesting to note
that while these abnormalities are commonly found in human patients with
neurocristopathy, additional OFT malformations often found in such patients,
including retroesophageal right subclavian artery and vascular rings, were not
observed in this study; this is likely because these latter two lesions are generally
associated with abnormal persistence of structures which normally regress during
development, rather than with the failure of such structures to form appropriately
(Stoller and Epstein, 2005).
In the pharyngeal arches, populations of neural crest cells, pharyngeal
endoderm, epithelial cells and cardiomyocytes exist in close association with one
another, and exert important regulatory roles mediating cell-cell communication.
The signals between these cells exist in a delicate balance, and are instrumental
for coordinating their migration, proliferation and differentiation. Cardiac OFT
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malformations have been described as a common endpoint for disruptions to
these processes in the pharyngeal arches; indeed, numerous mouse models in
which crosstalk between progenitor cell populations is disrupted result in a wide
array of OFT defects (Jain et al., 2010, Huh and Ornitz, 2010, Guo et al., 2011,
Zhang et al., 2010b, Newbern et al., 2008, Vallejo-Illarramendi et al., 2009, High
et al., 2008). Notch signaling via the Jagged1 ligand has previously been shown
to initiate a cascade of smooth muscle differentiation in the aortic arch arteries,
as well as to upregulate the expression of Jagged1 itself, in a positive feedback
loop (High et al., 2008, Feng et al., 2010). The decreased expression of Jagged1
in the aortic arch arteries of Hdac3Wnt1NCKO embryos suggests that Hdac3 may be
required

for

Notch-mediated

upregulation

of

Jagged1

and

subsequent

propagation of smooth muscle differentiation in the aortic arch arteries. Future
work will elucidate the direct targets of Hdac3 that are responsible for its
regulation of smooth muscle differentiation and Jagged1 be it through direct
deacetylation of transcription factor targets, or via epigenetic silencing of target
loci.
In addition to its relevance to congenital heart disease, smooth muscle
formation is clinically important in the setting of coronary arterial stent restenosis,
where proliferation of smooth muscle cells results in neointimal hyperplasia.
Agents such as sirolimus, and rapamycin have been shown to be clinically useful
in preventing restenosis at least in part by shifting the balance of smooth muscle
cells from a proliferating, less differentiated phenotype towards a more quiescent
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and contractile cell type (Martin et al., 2004, Hegner et al., 2009). Many of the
pathways involved in smooth muscle formation in embryogenesis are thought to
be similarly involved in smooth muscle differentiation and vascular remodeling in
the adult (Owens et al., 2004). While we have demonstrated a requirement for
Hdac3 in smooth muscle differentiation during embryonic cardiac development,
additional work is needed to determine whether Hdac3 plays an analogous role in
smooth muscle formation and phenotypic modulation in the adult vasculature.
Hdac inhibitors are widely used therapeutic agents and have previously been
proposed as useful agents in the treatment of heart failure (Trivedi et al., 2007).
Given a potential role of Hdac3 in modulation of vascular smooth muscle
behavior, vascular effects of Hdac inhibitors in various patient populations,
including those with coronary disease and vascular stents, will be interesting
topics for future study.
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Materials and Methods

Mice
To evaluate the role of Notch signaling in mediating the cardiovascular
phenotype in Hdac3Wnt1NCKO mice, Wnt1-Cre; Hdac3f/+ mice were crossed to
Hdac3f/+; R26NICD/+ mice (Stanger et al., 2005). Additional crosses and
techniques are described in Chapter 2. All animal protocols were approved by the
University of Pennsylvania Institutional Animal Care and Use Committee.

Micrographs, Histology and immunohistochemistry
These techniques are described in Chapter 2. For gross pictures of OFTs,
image brightness and contrast were adjusted in Adobe Photoshop to enhance
OFT detail. OFT morphological diagrams were obtained by tracing and falsecoloring H&E images in Adobe Illustrator
Primary antibodies used for immunohistochemistry were anti-GFP goat
polyclonal (Abcam AB6673, 1:100), anti-GFP rabbit polyclonal (Invitrogen A11122, 1:200), rabbit polyclonal anti-HDAC3 (Santa Cruz sc-11417x, 1:10),
mouse monoclonal anti-SMA (Sigma A2547, 1:200), mouse polyclonal Anti-2H3
(Iowa Hybridoma Bank, 1:25), rabbit polyclonal anti-tyrosine hydroxylase
(Chimicon AB152, 1:500), rabbit polyclonal anti-Jagged-1 (Santa Cruz SC-8303,
1:10).
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All control versus mutant histological and immunohistochemical images
were taken at the same exposure and contrast settings, using NIS Elements
software. ImageJ software was used to merge images and for quantification of
neurofilament and tyrosine hydroxylase staining intensity. In some cases, ImageJ
was used to decrease image brightness, and this was performed identically in
control and mutant images. Quantification of dorsal root ganglion and adrenal
medulla size was performed using multiple serial sections from multiple control
and mutant samples that were matched for anatomical landmarks.
Cell number, proliferation and apoptosis in pharyngeal arches III-VI were
quantified by manually counting nuclei, pHistone H3-, or Tunel-positive cells,
respectively, in adjacent sections of the anatomically-defined pharyngeal arch
region in a blinded manner. For quantification of SMA and Jagged1 staining
intensity, serial sections from three severely affected E11.5 Wnt1-Cre; Hdac3f/f
embryos were compared to littermate Wnt1-Cre and Wnt1-Cre; Hdac3f/+ control
embryos. Quantification was performed using ImageJ in a blinded manner.

Whole mount immunostaining and optical projection tomography.
E10.5 embryos were fixed in 4% paraformaldehyde overnight. Embryos were
bleached for 30 minutes in 5% H2O2 in PBST, digested in 10µg/mL proteinase K
in PBST for 5 minutes and immunostained with mouse polyclonal Anti-2H3 (Iowa
Hybridoma Bank, 1:100). An HRP Conjugated secondary antibody and DAB
substrate kit (Vector Laboratories) were used to visualize peripheral nerves.
	
  
88	
  

For OPT scanning, immunostained embryos were dehydrated into 100%
methanol, embedded in 1% low-melt agarose, cleared overnight in 1:2 (v/v)
benzyl alcohol and benzyl benzoate, and scanned using the Bioptonics OPT
scanner (3001M) (Sharpe et al., 2002). Image stacks were reconstructed using
OsiriX software. Image contrast was optimized to reveal peripheral nerve
patterning.

Neural Tube Explant Assays
Mutant embryos were obtained from crosses in which Wnt1-Cre; Hdac3f/+;
Z/EG males were crossed to Hdac3f/f females, and age-matched control embryos
were generated from Wnt1-Cre; Z/EG males crossed to WT females. Control and
mutant embryos were dissected in parallel in a blinded manner. E9.5 embryos
were dissected in sterile Hankʼs balanced salt solution (HBSS) supplemented
with 1% penicillin/streptomycin. The neural tube from the otic placode to first
dorsal root ganglion was dissected and incubated in 0.75mg/mL type I
collagenase (Worthington biochemical) in HBSS for 20 minutes at 37°C. Using
tungsten needles, the neural tube was then microdissected from the surrounding
mesenchyme, split in half longitudinally, and plated on glass chamber slides precoated with 200µg/mL fibronectin (Roche). Explants were incubated for 48 hours
at 37°C and 5% CO2 in DMEM supplemented with 2% horse serum and 1%
penicillin/streptomycin. Following fixation and immunostaining, each GFP+ cell
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that had delaminated from the neural tube was scored as SMA-positive or SMAnegative.

Statistics
The chi-square test and studentʼs 2-tailed t test were used to ascertain
differences between groups. A x2 or p-value of less than 0.05 was considered
significant.
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Table 3.1. Late gestation cardiovascular and thymic abnormalities in
Hdac3Wnt1NCKO embryos.

E16.5-18.5

Wnt1-Cre

Wnt1-Cre; Hdac3f/f

IAA type B

0% (0/6)

32% (6/19)

Aortic arch hypoplasia

0% (0/6)

16% (3/19)

PTA

0% (0/6)

5% (1/19)

DORV

0% (0/6)

26% (5/19)

VSD

0% (0/6)

69% (11/16)

Thymic Dysplasia

0% (0/6)

100% (19/19)
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Table 3.2. Hdac3Pax3NCKO die by P1.

Pax3Cre/+; Hdac3f/+ x Hdac3f/+
P1

# Observed

Observed

# Expected

Expected

Hdac3+/+

6

0.08

9

0.13

Hdac3f/+

25

0.35

17

0.25

Hdac3f//f

13

0.18

9

0.13

Pax3Cre/+;; Hdac3+/+

9

0.13

9

0.13

Pax3Cre/+;; Hdac3f/+

18

0.25

17

0.25

Pax3Cre/+;; Hdac3f/f

0

0

9

0.13

Total
Chi Sq

71
0.01
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Table 3.3. Late gestation cardiovascular and thymic abnormalities
observed in Hdac3Pax3NCKO embryos recapitulate those observed using
Wnt1-Cre.

E16.5-18.5

Pax3Cre; Hdac3f/+

Pax3Cre; Hdac3f/f

IAA type B

0% (0/6)

50% (6/12)

Aortic arch hypoplasia

0% (0/6)

0% (0/12)

PTA

0% (0/6)

17% (1/12)

DORV

0% (0/6)

17% (2/12)

Dorsal edema

0% (0/6)

100% (12/12)

Thymic Dysplasia

0% (0/6)

100% (12/12)
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Figure 3.1
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Figure 3.1. Wnt1-Cre efficiently deletes Hdac3 in the pharyngeal arch
mesenchyme,

conotruncal

cushions

and

adrenal

medulla.

A-C,

Immunohistochemistry for GFP and Hdac3 A, Frontal sections of the pharyngeal
arches at E10.5. Neural crest derivatives expressing GFP populate the
pharyngeal arches of control (left) and mutant embryos. In control embryos,
Hdac3 is expressed throughout the pharyngeal arch region. Mutant embryos
show deletion of Hdac3 in the neural crest-derived pharyngeal mesenchyme
(arrows), with retention of Hdac3 expression in ectoderm and pharyngeal
endoderm (arrowheads). Roman numerals denote pharyngeal arch number. B.
Frontal sections of the conotruncal cushions at E10.5. Neural crest derivatives,
marked by GFP expression, are found in the conotruncal cushions in both control
(left) and mutant embryos. Mutant embryos demonstrate loss of Hdac3
expression in GFP-positive neural crest derivatives (arrowheads). C. Sagital
sections of E14.5 adrenal glands. The adrenal medulla of control (left) and
mutant embryos is populated by neural crest derivatives. Mutants demonstrate
loss of Hdac3 expression specifically in GFP-positive cells (arrows), which
represent chromaffin cells. Scale bars: D. Quantification of cells in the pharyngeal
mesenchyme of aortic arches III-VI from serial sections of E11.5 control and
mutant embryos. A & B. 100μm, C. 400μm

	
  
95	
  

Figure 3.2
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Figure

3.2.

Late

gestation

Hdac3Wnt1NCKO

embryos

exhibit

severe

cardiovascular abnormalities. A-C. Gross images and drawings of E17.5 aortic
arches. A. A control embryo, showing normal patterning of the great vessels in
late gestation. B. A mutant embryo demonstrating a complete discontinuity of the
aortic arch (open bracket), similar to interrupted aortic arch type B in humans. C.
A mutant embryo showing hypoplasia of the aortic arch (arrowhead). A, aorta; P,
pulmonary trunk; RS, right subclavian artery; RC, right common carotid artery;
LC, left common carotid artery; LS, left subclavian artery. D. Sequential H&Estained slides from the same control (top) and mutant hearts. In the control heart,
the pulmonary trunk arises from the right ventricle (RV) while the aorta arises
from the left ventricle (LV). In this mutant, both the pulmonary trunk and the aorta
(arrow) arise from the right ventricle, indicating a double outlet right ventricle. E.
A control embryo (top) with an intact ventricular septum and a littermate mutant
with a large ventricular septal defect (*). The ventricular septal defect is the only
cardiac abnormality in this mutant. Scale bars: A-C. 1mm, D,E. 300μm.
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Figure 3.3
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Figure 3.3. Cardiac abnormalities in late gestation Hdac3Pax3NCKO embryos.
Sequential H&E- stained slides from the same control (top) and mutant hearts. In
control hearts, the pulmonary trunk arises from the right ventricle (RV) while the
aorta arises from the left ventricle (LV). In this mutant, both the pulmonary trunk
and the aorta (arrow) arise from the right ventricle, indicating a double outlet right
ventricle. Scale bar: 300μm.
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Figure 3.4
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Figure 3.4. Hdac3Wnt1NCKO embryos exhibit thymic abnormalities. Gross
pictures of the mediastinum of control and mutant embryos at E16.5. By E16.5
the thymus (outlined in broken white line) normally sits ventral to the atria, as
shown in the control (left). The mutant thymus is irregularly-shaped and has
failed to descend correctly. Scale bar: 1mm.
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Figure 3.5
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Figure 3.5. Peripheral neurogenesis occurs normally in the absence of
neural crest expression of Hdac3. A. Immunohistochemistry for GFP and
neurofilament (2H3), a marker of differentiated neurons, in frontal sections of the
dorsal neural tube (DNT) and dorsal root ganglia (DRG). Both control and Mutant
DRG feature differentiated, 2H3-positive neurons at E10.5 (arrowheads). B. Total
neuronal area was calculated from anatomically matched sections from control
and mutant embryos. Error bars represent SEM. N.S., not significantly different.
C. Optical projection tomography renderings of whole mount 2H3-stained E10.5
embryos. Cranial nerves V, VII-XII (labeled) and DRG are present and patterned
appropriately in mutant embryos. Scale bars: A. 100μm, B. 400μm.
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Figure 3.6
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Figure 3.6. Chromaffin cells of the adrenal medulla develop normally in the
absence of Hdac3. Immunohistochemistry for GFP and tyrosine hydroxylase
(TH), a marker of neuroendocrine cells, in sagital sections of adrenal glands.
Control (left) and mutant adrenal medulla are populated by TH-positive, neural
crest-derived chromaffin cells. Quantification of TH- positive area was obtained
from two serial sections of five control and five mutant adrenal glands. Scale bar:
100μm.
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Figure 3.7
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Figure 3.7. Hdac3Wnt1NCKO embryos display deficiencies in aortic arch artery
smooth muscle at E11.5. A-H. Immunohistochemistry for GFP and α-smooth
muscle actin (SMA) in frontal sections of E11.5 pharyngeal arches. A.
Representative image of a control pharyngeal arch at low magnification, showing
robust layers of smooth muscle surrounding aortic arch arteries II, III, IV and VI
(labeled), bilaterally. Note that the bulk of pharyngeal mesenchyme is comprised
of GFP-positive neural crest derivatives. B-D. High magnification images of the
left fourth arch artery in the control embryo. B. Neural crest cells populate the
region directly surrounding the artery. C,D. A layer of neural crest-derived, SMApositive smooth muscle surrounds the control artery. E. Low magnification image
of a mutant pharyngeal arch, showing neural crest derivatives populating the
mesenchyme. Note the decreased smooth muscle in the regions surrounding the
third, fourth and sixth arteries, particularly on the left side, while a thick layer of
non-neural crest-derived smooth muscle surrounds the second arteries, as in the
control F-H. High magnification images of the mutant left fourth artery. F. Neural
crest cells appropriately populate the region surrounding the artery. G,H. In
affected mutants, few neural crest-derived cells surrounding the fourth arch artery
are SMA-positive smooth muscle cells. Three of four mutant and zero of four
control embryos analyzed at this time point showed a similar pattern of staining.
Roman numerals denote aortic arch artery number. I. Quantification of SMA
staining intensity of each aortic arch artery, from serial sections in control and
mutant embryos. Asterisks denote p < 0.05. J. Quantification of phospho-histone
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H3 (pH3)- and Tunel-positive in serial sections of the pharyngeal arch
mesenchyme. Scale bars: 100μm.
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Figure 3.8
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Figure 3.8. Hdac3Wnt1NCKO pharyngeal arches display decreased expression
of the smooth muscle marker Sm22α in the aortic arch arteries at E11.5.
Immunohistochemistry for Sm22α and Hdac3 in frontal sections from E11.5
pharyngeal arches. Hdac3 is deleted in the neural crest-derived cells surrounding
the nascent pharyngeal arches in mutant embryos. These embryos are also
characterized by decreased expression of Sm22α. High magnification images
show the left sixth artery. Scale bars: 100μm.
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Figure 3.9

	
  
111	
  

Figure 3.9. Hdac3-deficient neural crest cells demonstrate a cell
autonomous

defect

in

smooth

muscle

differentiation.

A-F.

Immunocytochemistry for GFP and α-smooth muscle actin (SMA) in neural tube
explant cultures. A,B. Representative images of control and mutant neural crest
cells following two days of migration and growth. Note that mutant neural crest
cells (B) are small and blastic compared to control cells (A). C-F. Significant
numbers of control cells stain positive for SMA (C,E) while mutant cells are rarely
SMA-positive (D,F). G. Each GFP-positive cell derived from four control and four
mutant embryos was scored as SMA-positive or -negative. Scale bar: 100μm.
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Figure 3.10

	
  
113	
  

Figure 3.10. Expression of the Notch ligand Jagged1, a critical regulator of
smooth muscle differentiation in the aortic arch arteries, is dysregulated in
Hdac3Wnt1NCKO arches at E11.5. A. Representative immunohistochemistry for
SMA and Jagged1 from frontal sections of mutant versus control left fourth and
sixth arch arteries. B. Quantification of Jagged1 staining intensity in serial
sections from three severely affected mutants relative to controls. Scale bar:
100μm.
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Figure 3.11
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Figure 3.11. Overexpression of the notch intracellular domain partially
restores smooth muscle

in developing aortic arch arteries. A-L.

Immunohistochemistry for SMA and Jagged1 in frontal sections from E11.5
embryos at the confluence of the right fourth and sixth aortic arch arteries. A-C. A
Control embryo showing the normal morphology at E11.5. Note the
discontinuities in SMA staining in the region surroundind the fourth and sixth arch
ateries. D. SMA staining in the setting of Notch overexpression in neural crest.
Note the robust layer of smooth muscle surrounding the confluence, which is
more robust than in the littermate control embryo. E-F. With overexpression of
Notch, areas of ectopic Jagged1 expression are observed (open bracket),
consistent with the existence of a Notch-Jagged1 positive feedback loop. G-I. In
a litermate Hdac3Wnt1NCKO mutant, there are large areas of discontinuous SMA
staining and decreased expression of Jagged1. J. Overexpression of NICD in the
Hdac3Wnt1NCKO background in a littermate embryo results in robust SMA staining
in the confluence. K-L. Ectopic Jagged1 expression is not observed in this
embryo. Roman numerals delineate arch arteries. Scale bar: 50μm.
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Chapter 4. Conclusions and future directions

Summary
The development of complex organisms is driven by the genesis of
multiple distinct cell types from common progenitor cells. Given that each
differentiated cell possesses the same genome as its progenitor cell precursor
but exhibits a unique transcriptional and phenotypic profile, development is an
inherently epigenetic process. The epigenetic regulation of progenitor cell biology
has become an area of increasing investigation. Chromatin remodeling enzymes,
including class I Hdacs, have proven to be important regulators of many aspects
of progenitor cell behavior, including their differentiation. Furthermore, class I
Hdacs have now been implicated in the converse process – the de-differentiation
of committed cells into induced pluripotent progenitor cells (Anokye-Danso et al.,
2011).
In this dissertation, I have used mouse genetics to explore the role of the
chromatin remodeling enzyme Hdac3 in regulating distinct aspects of neural crest
progenitor cell biology. In Chapter 2, I discuss the role of Hdac3 in neural crestmediated craniofacial development. I have suggested that Hdac3 is required for
the repression of the signaling molecule Bmp4 in neural crest cells, and that in
the absence of Hdac3, excessive Bmp4 signaling results in aberrant cell cycle
regulation and craniofacial abnormalities (Figure 4.1). Additionally, Hdac3 plays
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an important role in osteogenesis, in part, through regulation of the important
regulatory factor Runx2. In Chapter 3, I discuss the role of Hdac3 in cardiac
outflow tract formation. Hdac3 is required for neural crest-mediated smooth
muscle differentiation via the Notch signaling pathway (Figure 4.2). However,
with regard to the role of Hdac3 in each of these distinct aspects of neural crest
development, interesting questions, further discussed below, remain.
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Discussion and Future Directions

Is there a single, parsimonious explanation for the cardiac and craniofacial
abnormalities in Hdac3Wnt1NCKO embryos?
Craniofacial and cardiac abnormalities often segregate together, both in
human congenital abnormalities, and in mouse models in which various aspects
of neural crest development have been genetically perturbed (Benish, 1975, Huh
and Ornitz, 2010, Guo et al., 2011, Zhang et al., 2010b, Newbern et al., 2008,
Vallejo-Illarramendi et al., 2009). Deletion of Hdac3 in neural crest yields an array
of abnormalities reminiscent of those found both in patients with DiGeorge
syndrome and in numerous murine models of neural crest abnormalities in which
a single process has been disrupted. Therefore we have asked whether there
exists a single, parsimonious explanation for the spectrum of abnormalities
described in Hdac3Wnt1NCKO mice. The mechanistic analysis of the craniofacial
and cardiovascular phenotypes, presented in Chapters 2 and 3, however,
suggests that dysregulation of a single gene or pathway is unlikely to account for
the phenotype of Hdac3Wnt1NCKO mice.
In cardiac outflow tract (OFT) development, we found that loss of Hdac3
results in decreased smooth muscle differentiation. We have implicated
decreased Notch signaling via the Jagged1 ligand as one mechanism through
which this smooth muscle differentiation defect occurs. Notch signaling is not
involved in most aspects of craniofacial morphogenesis, including palatogenesis,
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suggesting that the majority of craniofacial abnormalities in Hdac3Wnt1NCKO pups
do not occur due to Notch inhibition. However, Notch inhibition in neural crest –
either by genetic deletion of Jagged1 or by expression of a dominant negative
form of the transcription factor MAML - results in ossification abnormalities of the
frontal bone (Frances High, unpublished). These abnormalities are similar to
frontal bone abnormalities observed in Hdac3Wnt1NCKO pups. Therefore the
Hdac3-mediated regulation of Jagged1 expression may, in part, contribute to the
ossification defects observed in Hdac3Wnt1NCKO embryos. However, Notch
inhibition is unlikely to contribute to additional craniofacial abnormalities.
In Chapter 1, I describe that the survival of cranial neural crest derivatives
is significantly decreased in the absence of Hdac3, while in Chapter 2 I show that
proliferation and apoptosis in cardiac neural crest are unaffected. The decrease
in survival in craniofacial crest – mediated by dysregulation of a Bmp4-Msx2
pathway, is consistent with many of the craniofacial abnormalities identified in
Hdac3Wnt1NCKO mutants. In OFT development, Bmp4 and Msx genes are actually
required for smooth muscle differentiation, cardiac crest survival and OFT
remodeling, suggesting that their upregulation would not portend the OFT defects
observed in Hdac3Wnt1NCKO embryos (Stottmann et al., 2004, Chen et al., 2007,
Nie et al., 2011, Zhang et al., 2010a). Indeed, ectopic activation of Bmp or Msx
activity in vivo in the neural crest does not produce OFT defects (Winograd et al.,
1997, He et al., 2010).	
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Our results therefore suggest that Hdac3 mediates distinct processes in

craniofacial and cardiovascular development, and that dysregulation of a single
gene or pathway is unlikely to account for the full spectrum of abnormalities
described in this dissertation.

What is the nature of Hdac3-mediated repression of Bmp4?
Bmp signaling – particularly from ectodermal structures to neural crest
cells - is important in multiple stages of craniofacial development (He et al., 2010,
Zhang et al., 2000, Nie et al., 2006, Zhang et al., 2002). Bmp4 is expressed in
the dorsal neural tube prior to neural crest cell delamination, and in the chick this
signal has been shown to mediate apoptosis in a subset of neural crest cells
(Graham et al., 1994). Later, as neural crest cells populate the face, Bmp signals
from the epithelium regulate the survival and expansion of those cells, particularly
in palatogenesis and tooth formation (Zhang et al., 2000, Zhang et al., 2002). We
have proposed a model in which Hdac3 restricts Bmp4 transcription in cranial
neural crest, in order to regulate the growth and survival of these cells. We have
demonstrated that loss of Hdac3 leads to upregulation of Bmp4, upregulation of
targets of Bmp4 signaling, and craniofacial abnormalities. However, some
craniofacial abnormalities described in this study, including ossification defects,
have not previously been associated with increased Bmp4 activity. While
ectodermal expression of Bmp4 is required for craniofacial morphogenesis,
studies using a floxed allele of Bmp4 have revealed that deletion of Bmp4 in
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neural crest tissue itself does not affect craniofacial morphogenesis (Neves et al.,
2011). A useful experiment for discerning which abnormalities in Hdac3Wnt1NCKO
embryos are mediated by cell autonomous upregulation of Bmp4 in neural crest
cells would involve rescuing the defects on a Bmp4flox/flox background. Our model
would predict that craniofacial hypoplasia, cleft palate and dental abnormalities
would be rescued by deletion of Bmp4, while ossification abnormalities would
persist.
The transcriptional regulation of Bmp4 expression is a complex area of
investigation. LacZ reporters spanning a 180kb region flanking the Bmp4 coding
sequence recapitulate only a small fraction of the normal Bmp4 expression
pattern during embryogenesis (Chandler et al., 2009). The Bmp4 gene exists in a
highly conserved gene desert of over 1MB (Pregizer and Mortlock, 2009). This
region is believed to contain multiple enhancer elements that drive Bmp4
expression, although the locations of these enhancers remain largely unknown
(Pregizer and Mortlock, 2009). In light of the role of Hdac3 as a transcriptional
repressor, we have hypothesized that Hdac3 directly represses Bmp4 expression
in neural crest by deacetylating histones at one or more of these Bmp4 enhancer
element. While relevant enhancers driving neural crest expression of Bmp4
remain undescribed, ChIP-Seq for Hdac3 in cranial crest would identify potential
sites of Hdac3 regulation in neural crest. Putative sites could then be cloned
upstream of reporters in order to determine whether they direct neural crest
transcription in the presence or absence of Hdac3. This approach could address
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the question of whether Hdac3-mediated inhibition of Bmp4 transcription is direct
or indirect, and could also contribute to our understanding of how Bmp4
transcription is regulated by distant-acting enhancers.

What is the nature of the genetic interaction between Hdac3 and Notch
signaling in OFT development?
In Chapter 3 I describe a genetic interaction between Hdac3 and the
Notch-Jagged1 positive feedback loop in smooth muscle differentiation. Notch
signaling activates smooth muscle differentiation in a cell autonomous manner
(High et al., 2007). As well, smooth muscle differentiation in the aortic arch
arteries relies on this feedback loop to propagate the differentiation signal from
the endothelium into the surrounding neural crest-derived mesenchyme (High et
al., 2008, Feng et al., 2010). The evidence presented in Chapter 3 suggests that
Hdac3 is required for Notch-mediated upregulation of Jagged1 expression, but
not for cell autonomous NICD-mediated smooth muscle differentiation. However
the nature of this requirement is unclear.
A plausible model to explain the interaction between Hdac3 and Notch
signaling is one in which Hdac3 is responsible for repressing the expression of
an inhibitor of the positive feedback loop via its role as a chromatin remodeling
enzyme. Thus, in the absence of Hdac3, the positive feedback loop would be
broken, with resulting deficiencies in smooth muscle differentiation. Smooth
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muscle differentiation involves complex interactions between multiple signaling
pathways, and it has been hypothesized that there is extensive positive and
negative cross-regulation between these pathways (Owens et al., 2004).
Therefore a screen among pathway components of these signaling pathways as
well as additional known Notch inhibitors could prove fruitful for identifying
potential inhibitors of Notch-mediated Jagged1 expression that are derepressed
in the absence of Hdac3.

Is Hdac3 required for differentiation and/or survival of additional smooth
muscle populations?
As discussed in Chapter 3, determining the mechanism of smooth muscle
differentiation is relevant not only to developmental and regenerative biology, but
to the study of adult disease processes (Yoshida and Owens, 2005). In Chapter
3 I discuss a novel and important pathway that regulates neural crest-derived
smooth muscle differentiation, and we are interested in the applicability of this
mechanism to additional developmental processes. One useful strategy for
determining whether Hdac3 is required for differentiation of other smooth muscle
populations, or for the survival of differentiated smooth muscle cells, is to cross
the Hdac3f allele to existing Cre lines and analyze smooth muscle derivatives in
late gestation.
The smooth muscle of the descending aorta and much of the body
vasculature is derived from the lateral plate mesoderm. Mice in which Hdac3 is
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deleted with the mesoderm-specific Mesp1-Cre die at E9.5, and preliminary
analysis reveals evidence of circulatory collapse consistent with a failure of the
vasculature to be formed correctly. However, preliminary analysis of Sema3DCre; Hdac3f/f embryos, in which Hdac3 is deleted in precursors of the smooth
muscle of the coronary vasculature, suggests that these mice develop normally.
Detailed analysis of these mice will reveal whether the requirement for Hdac3 in
smooth muscle differentiation applies only to specific smooth muscle lineages.
Based on the normal rates of proliferation and apoptosis observed in
Hdac3Wnt1NCKO E11.5 aortic arch arteries, we hypothesized that deletion of Hdac3
does not affect the survival of differentiated smooth muscle cells. Sm22α-Cre is
expressed in committed, early stage smooth muscle cells. Preliminary analysis of
Sm22α-Cre; Hdac3f/f embryos suggests that deletion of Hdac3 using Sm22α-Cre
does not affect patterning of the OFT and aortic arch, supporting our hypothesis
that Hdac3 is required for smooth muscle differentiation, but ultimately not for the
survival of differentiated cells.

How is Hdac3 targeted to genomic loci in different neural crest lineages?
As discussed in Chapter 2, the Hdac3-NCoR/Smrt corepressor complex
does not possess intrinsic DNA binding ability. Rather, it is targeted to specific
genomic loci by transcription factor and nuclear receptor binding partners. We
have hypothesized that the preponderance of abnormalities resulting from the
loss of Hdac3 in neural crest occurs due to the loss of Hdac3-mediated
	
  
125	
  

transcriptional repression at specific loci. Therefore an exciting area of research
will involve determining the binding partners of the Hdac3 coreprssor complex
that lead to its genomic localization in neural crest.
Interesting candidate transcription factors include Hox family members,
including Msx proteins. Hox proteins are differentially expressed along the rostrocaudal axis of neural crest and bind DNA in a sequence-specific manner
(Marshall et al., 1992). In many developmental contexts, they have been shown
to act both as transcriptional activators and transcriptional repressors - the latter
activity occurring through direct interaction with chromatin remodeling complexes,
incuding Hdac3-NCoR/SMRT (Saleh et al., 2000). Interestingly, abnormalities in
Hox gene expression can cause a number of the defects observed with Hdac3
deletion	
  (Makki and Capecchi, 2011).
Hdac3 ChIP-Seq studies described above would be useful for determining
whether Hox proteins or additional classes of transcription factors dictate the
genomic localization of Hdac3 in neural crest. Bioinformatic analysis of neural
crest Hdac3 enrichment sites determined by ChIP-Seq could reveal putative
binding sites for known transcription factors, including Hox proteins. Predicted
interacting partners could then be validated by Co-IP and sequential ChIP
experiments.
Given that work in the liver has suggested that a single factor may
influence global Hdac3 localization within a given tissue (Feng et al., 2011), an
unbiased screen for Hdac3 protein interacting partners in neural crest cells could
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also identify the mediators of Hdac3 genomic targeting. In such a screen, Hdac3
would be precipitated from neural crest cells and its interacting partners identified
by mass spectrometry. To this end, we have designed and are cloning a
construct in which Hdac3 is tagged with an AviTag that leads to its biotinylation 	
  
(Wang et al., 2006). This strategy has previously been used to identify interaction
networks between transcription factors and chromatin remodeling enzymes in
early developmental processes (Wang et al., 2006). Biotin-tagged Hdac3 could
be expressed in cultured neural crest cells and precipitated with high affinity by
streptavadin; such a strategy would maximize the signal to noise ratio in a
proteomic screen for Hdac3 interacting partners, and identify candidate
interactions that could be further explored.

Are the functions of Hdac3 in neural crest mediated by interactions with
non-histone proteins?
Classically,

Hdacs

act

as

transcriptional

repressors

by

directly

deacetylating histone tails. However, class I Hdacs can also regulate
transcription by directly deacetylating non-histone targets (LeBoeuf et al., 2010).
Hdac3 has been proposed to directly deacetylate Mef2d and p53 to regulate their
activity (Gregoire et al., 2007, Zeng et al., 2006). It is possible that the
phenotypes elicited by deletion of Hdac3 in neural crest arise due to
hyperacetylation of transcription factors in the absence of this important
regulatory enzyme.
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Interestingly, the class III Hdac Sirt1 has been shown to directly
deacetylate the Notch effector molecule NICD, suggesting the intriguing
possibility that Hdac3 could deacetylate NICD to regulate OFT development
(Guarani et al., 2011). However, this study identified the hyperacetylated form of
NICD as the active form, which is not consistent with a model in which Notch
activity is decreased in the absence of direct deacetylation from Hdac3.
One strategy to identify candidate transcription factors that may be direct
targets of Hdac3 deacetylation is to analyze microarray data from Hdac3deficient versus control tissue, in order to identify patterns of dysregulation
among the known targets of individual transcription factors. An additional strategy
to identify potential non-histone targets of Hdac3 deacetylation involves the use
of the unbiased proteomics screen described above. For candidates identified
through these strategies, interactions could subsequently be explored in the in
vitro model systems employed in Chapters 2 and 3.
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Concluding Remarks

The work described in this dissertation has identified downstream targets
and processes in neural crest development that are regulated by Hdac3. We
have shown that Hdac3 is essential for neural crest-mediated craniofacial and
cardiovascular development, while it is not required for neuroendocrine
development. An exciting area of future research will involve indentifying the
upstream pathways and stimuli that regulate Hdac3 function in neural crest cells.
These studies will shed further light on the molecular regulation of neural crest
development, and provide a more complete understanding of how external stimuli
are linked to heritable changes in progenitor cell gene expression.
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Figure 4.1
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Figure 4.1. Model of Hdac3 regulation of craniofacial development. Hdac3
regulates both neural crest cell survival as well as ossification during craniofacial
development. Regulation of ossification occurs through a Runx2-mediated
pathway. We propose that Hdac3 is responsible for repressing a repressor of
ossification, through histone deacetylation. Hdac3-mediated regulation of the cell
cycle occurs through transcriptional silencing of Bmp4, which we hypothesize is
also mediated by the transcriptional repressive functions of the Hdac3 complex.
The histone deacetylase activity of Hdac3 requires its association with NCoR
and/or Smrt in a corepressor complex.
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Figure 4.2
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Figure 4.2. Model of Hdac3 regulation of cardiac outflow tract development.
Smooth muscle differentiation in the aortic arch arteries relies on a NotchJagged1 positive feedback loop. Hdac3 is required for propagation of this
feedback loop in neural crest cells. We hypothesize that Hdac3, through its
activity as a transcriptional repressor, inhibits the expression of an inhibitor of this
process.
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Appendix. Diet induced lethality due to deletion of the
Hdac3 gene in heart and skeletal muscle

This appendix contains data that has been published in the Journal of Biological
Chemistry in a collaborative project with the Zheng Sun of the Lazar lab (Sun et
al., 2011). In addition to experimental design and data analysis, I directly
contributed data in figures 1A, 2B,D, 3A,C,D.

Summary

In chapter 1, I discussed phenotypes arising from cardiac deletion of
Hdac3 in different stages of cardiac development. Briefly, deletion of Hdac3 in
bipotent progenitor cells results in premature cardiomyocyte differentiation and
proliferation defects; deletion of Hdac3 in ventricular cardiomyocytes results in
inefficient lipid metabolism, leading to oxidative damage, progressive heart failure
and death.
In this appendix, I describe the results of Hdac3 deletion in differentiated
cardiomyocytes. In the context of the aforementioned studies of Hdac3 in cardiac
development, this work provides an example of the differential roles played by
Hdac3 within a single cell lineage at different developmental time points.
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Results and Discussion

Excising Hdac3 with Cre recombinase under the control of the muscle
creatine kinase promoter (Mck-Cre) results in progressive deletion of Hdac3 in
cardiomyocytes and skeletal muscle during the perinatal period (Appendix,
Figure 1). Mck-Cre; Hdac3f/f mice fed a normal diet (11% kcalories from fat) are
viable, with no reduction in survival (Appendix, Figure 2A). At 4 months of age,
they show mild cardiac hypertrophy, but no upregulation of markers of heart
failure (Appendix, Figure 2B,C). Echocardiography reveals increases in ejection
fraction and fractional shortening, consistent with mild, early stage cardiac
disease, and histological analysis of 8 month old hearts shows mild infiltrate at 8
months of age (Appendix, Figure 2D-F).
Expression profiling of 4-month-old Mck-Cre; Hdac3f/f hearts reveals that a
different subset of metabolic genes is dysregulated, compared to in αMHC-Cre;
Hdac3f/f hearts (Appendix, Table 1). Genes found to be downregulated in MckCre; Hdac3f/f hearts include important regulators of the mitochondrial response to
lipid overload (Appendix, Table 1). Therefore when placed on a high fat diet (60%
fat by kilocalorie), these mice exhibit profound cardiac defects. Four-month-old
Mck-Cre; Hdac3f/f mice treated for three months on a high fat diet demonstrate
pronounced cardiac hypertrophy, as measured by heart weight: tibial length ratio,
expression of markers of heart failure, and increased myocyte diameter
(Appendix,

Figure

3A-D).

These

hypertrophic
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hearts

are

functionally

compromised, with significant decreases in contractility and ejection fraction, as
well as wall motion abnormalities consistent with destruction of normal
myocardial architecture (Appendix, Figure 3E,F). Histological analysis confirms
this disruption of normal myocardial architecture, revealing significant fibrosis and
a mononuclear cell infiltrate in Mck-Cre; Hdac3f/f hearts (Appendix, Figure 3D).
These cardiac abnormalities lead to lethality between 4-6 months (Appendix,
Figure 3G). The severity of the cardiac abnormalities in Mck-Cre; Hdac3f/f mice
on a high fat diet lies in stark contrast to the subtle abnormalities of littermate
controls fed normal chow, demonstrating an important interaction between
environmental stimuli – in this case the nutritional environment – and the function
of Hdac3 as a modulator of gene expression.
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Table A.1. Genes differentially expressed in 6 week old (normal diet) MckCre; Hdac3f/f versus Hdac3f/f hearts

!
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Figure A.1
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Figure A.1. Efficient postnatal deletion of Hdac3 In Mck-Cre; Hdac3f/f
hearts. A. qPCR analysis of Hdac3 transcript in mice at the age of 1-day, 1week, 3-week, and 6-week. n=4. Arbp was used as a reference control. Error bar
= S.E.M. Asterisks indicate p < 0.05 by two-sided studentʼs t-test. B, Western blot
analysis of 4-month-old mice. KO: Mck-Cre; Hdac3f/f. WT: littermate Hdac3f/f.
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Figure A.2
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Figure A.2. Mild alterations in Hdac3-deficient hearts on normal chow. A.
Kaplan-Meier survival curves and body weight are unchanged on normal chow.
n=12-15. B. Gross picture of hearts at the age of 4-months, and heart weight
(HW) to tibia length (TL) ratio of 4-month-old mice on normal chow. n=7-8. C.
qPCR analysis of 4-month-old mice for cardiac atrial natriuretic peptide (ANP)
and brain natriuretic peptide (BNP), markers for heart failure. n=3. D. Trichrome
stain of hearts from 8-month-old mice, revealing normal myocardial architecture.
E-F. Echocardiography analysis of cardiac structure and function on 4-month-old
mice on normal chow. . n=4-5. E. Parameters measuring cardiac function reveal
subtle abnormalities in Hdac3-deficient hearts, representing increased cardiac
function. EF: left ventricular ejection fraction FS: left ventricular fractional
shortening.

F.

Parameters

measuring

cardiac

structure

reveal

subtle

abnormalities in Hdac3-deficient hearts. IVRT: isovolumic relaxation time; LVIDd:
left ventricular diameter during diastole; LVIDs: Left ventricular diameter during
systole; LA: left atrium area; LVPW: LV posterior wall thickness during diastole;
RVAW: right ventricular anterior wall thickness; IVS: interventricular septal
thickness during diastole.
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Figure A.3

	
  
142	
  

Figure A.3. Dietary lipid overload induced severe cardiac defects in mice
lacking cardiac Hdac3. A. Gross picture and heart weight (HW) to tibia length
(TL) ratio of hearts from 4-month-old mice after 3 months on a high fat diet
(HFD). n=4-5. B. qPCR analysis of myocardial ANP and BNP from 4-month-old
mice. n=4-5. C. Wheat germ agglutinin (WGA) staining of cross sections of
ventricles from 4-month-old mice on HFD. Myocyte diameter was quantified using
6 random 20x fields of view from 3 WT and 5 KO hearts. D. Trichrome stain of
hearts from 4-month-old mice on HFD shows extensive areas of fibrosis (blue)
and destruction of normal myocardial architecture. E-F. Echocardiography
analysis of cardiac structure and function on 4-month-old mice on high fat diet.
n=4-5. E. Cardiac structure data. F. Contractile function data and representative
short-axis M-mode images from echocardiography. G. Kaplan-Meier survival
curves on high fat diet (HFD). n=10 for WT, n=12 for KO. KO mice have normal
weight gain on HFD.
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